Respiratory diseases principally affecting the interstitium, IBD co-morbidites

IBD_PULM

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints J10_PULMEOS J10_OTHERINSTPULM	6271
6. Filter based on genotype QC (FinnGen only)	6271

Control definitions (FinnGen only)

Control exclude: IBD_COMORB

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	IBD_PULM
CONTROL_EXCLUDE	IBD_COMORB
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	J10_PULMEOS\|J10_OTHERINSTPULM
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Respiratory diseases principally affecting the interstitium, IBD co-morbidites based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6271	2542	3729
Unadjusted period prevalence (%)	1.33	0.87	1.64
Median age at first event (years)	68.77	65.91	70.72

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3378: Matched controls
28971

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

TGC00

NOMESCO Finland

Bronchial lavation

73.8

323.0

859

133

UGC12

NOMESCO Finland

Flexible bronchoscopy

20.9

323.0

1196

740

G47.3

ICD-10 Finland

Sleep apnoea

33.2

323.0

676

216

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

49.2

323.0

664

143

215

Kela drug reimbursment

Diabetes, non-insulin-treated

343.0

323.0

618

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

61.9

323.0

807

146

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

62.4

323.0

669

114

R06.0

ICD-10 Finland

Dyspnoea

7.7

323.0

1245

2036

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

319.9

323.0

393

A10BA02

ATC

metformin; oral

67.4

323.0

702

112

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

5.8

323.0

1546

3681

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

5473.0

323.0

952

GD1AA

NOMESCO Finland

Thorax X-ray examination

9.2

323.0

2172

4727

N02AX02

ATC

tramadol; systemic, rectal

5.0

323.0

1431

3728

J18.9

ICD-10 Finland

Pneumonia, unspecified

9.4

323.0

1588

2490

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

16384.0

323.0

1324

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

15.1

323.0

1245

1073

T90

ICPC

Diabetes non-insulin dependent

19.7

323.0

621

327

XG410

NOMESCO Finland

Flow-volume spirometry

24.7

323.0

508

206

103

Kela drug reimbursment

Diabetes, insulin-treated

208.1

323.0

711

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

16384.0

323.0

1640

P01BA02

ATC

hydroxychloroquine; oral

58.1

323.0

499

A02BC02

ATC

pantoprazole; systemic

4.8

323.0

2346

9334

H02AB06

ATC

prednisolone; systemic

11.8

323.0

2517

5727

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

59.5

323.0

1167

254

R03AC02

ATC

salbutamol; inhalant

4.5

323.0

2058

7453

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

778.5

320.5

329

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

17.0

317.6

544

323

C03CA01

ATC

furosemide; systemic

5.5

312.6

1135

2436

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

12.5

289.3

566

457

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

158.6

288.9

319

284

Kela drug reimbursment

Nintedanib and pirfenidone

+∞

276.1

277

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

23.5

273.6

417

172

M17.1

ICD-10 Finland

Other primary gonarthrosis

15.8

269.9

475

297

L04AX01

ATC

azathioprine; systemic

18.7

265.4

437

228

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

+∞

243.8

245

GD1AD

NOMESCO Finland

Thorax CT examination

13.9

243.3

451

317

M48.0

ICD-10 Finland

Spinal stenosis

75.4

242.9

290

L04AA06

ATC

mycophenolic acid; systemic

66.8

241.4

293

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

10.0

240.4

528

527

N03AX16

ATC

pregabalin; oral

6.8

238.8

684

1044

J45.9

ICD-10 Finland

Asthma, unspecified

5.8

237.9

778

1412

356

Kela drug reimbursment

Nintedanib and pirfenidone

+∞

235.7

237

SPAT1262

SPAT

Handing over of treatment supplies

8.7

235.3

563

652

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

4.4

235.3

1073

2793

A07EC01

ATC

sulfasalazine; oral, rectal

21.8

232.7

363

159

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

30.9

229.6

324

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

546.2

228.7

238

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

24.6

228.5

343

132

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

22.7

228.1

351

147

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

+∞

224.6

226

M05BA04

ATC

alendronic acid; oral

10.5

224.3

478

448

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.6

220.8

1363

4579

N02BE01

ATC

paracetamol; systemic, rectal

3.5

219.9

2648

14614

J01MA14

ATC

moxifloxacin; systemic

7.5

218.0

576

775

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

7.2

212.5

579

813

R5140

NOMESCO Finland

Monitoring the use of the aid

17.6

208.5

350

189

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

5.3

208.2

733

1430

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

140.8

205.8

230

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.4

205.2

705

1335

N03AX12

ATC

gabapentin; oral

11.7

204.8

411

339

AA1AD

NOMESCO Finland

CT of head and brain

6.4

204.4

605

950

R03BB04

ATC

tiotropium bromide; inhalant

6.6

202.4

584

885

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

4.4

202.2

874

2114

J01MA12

ATC

levofloxacin; systemic

4.5

201.8

851

2008

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

8.9

200.1

468

514

Z01.8

ICD-10 Finland

Other specified special examinations

4.8

199.4

786

1728

R4110

NOMESCO Finland

Physiotherapy

3.9

198.3

1020

2891

N02AJ06

ATC

codeine and paracetamol; systemic

3.8

198.0

1045

3027

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

67.1

197.6

240

A10BH01

ATC

sitagliptin; oral

1726.1

195.2

199

G56.0

ICD-10 Finland

Carpal tunnel syndrome

22.2

194.4

301

127

E11

ICD-10 Finland

Type 2 diabetes mellitus

18.0

193.0

321

168

M79.6

ICD-10 Finland

Pain in limb

4.0

189.8

914

2428

Z3226

NOMESCO Finland

Physiotherapist

5.2

187.9

677

1342

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

63.5

187.2

229

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

45.2

185.9

241

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

93.1

183.8

214

TPH04

NOMESCO Finland

Cathetrisation of vein

4.2

181.4

820

2044

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

16.9

181.0

308

171

M25.5

ICD-10 Finland

Pain in joint

4.7

180.3

720

1587

C07AB07

ATC

bisoprolol; oral

3.0

180.0

1501

6048

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

13.8

179.8

332

226

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

6.7

176.6

498

723

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

9.2

174.9

398

413

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

61.3

174.7

215

L04AX05

ATC

pirfenidone; oral

+∞

172.4

174

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

18.3

170.2

281

143

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

124.4

169.8

192

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

8.1

168.9

418

498

A10AE04

ATC

insulin glargine; parenteral

81.4

166.5

197

J01AA02

ATC

doxycycline; systemic

3.0

165.7

2619

15472

M54.5

ICD-10 Finland

Low back pain

4.0

164.8

791

2062

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

4.1

159.5

723

1783

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

103.5

158.9

183

R05

ICD-10 Finland

Cough

4.0

157.8

755

1954

M13.9

ICD-10 Finland

Arthritis, unspecified

20.9

154.3

243

107

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

9.3

154.1

347

351

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

+∞

153.4

155

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

3.6

149.5

824

2390

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

4.5

147.9

599

1316

A02BC05

ATC

esomeprazole; systemic

2.8

146.1

1257

4990

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

16.0

145.9

253

146

J01FA06

ATC

roxithromycin; oral

2.7

144.9

1374

5784

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.6

144.6

1654

7767

M16.1

ICD-10 Finland

Other primary coxarthrosis

26.7

144.3

211

A02BC01

ATC

omeprazole; systemic

3.3

143.0

901

2885

L04AA13

ATC

leflunomide; oral

276.3

142.7

153

I50.9

ICD-10 Finland

Heart failure, unspecified

5.3

142.6

486

884

R50.9

ICD-10 Finland

Fever, unspecified

4.5

141.5

571

1246

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

156.5

141.5

157

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

12.8

139.7

266

192

R03AK06

ATC

salmeterol and fluticasone; inhalant

4.3

139.6

598

1382

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

10.3

139.0

295

266

J01DB01

ATC

cefalexin; oral

2.6

138.7

2492

14890

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

+∞

138.4

140

M75.1

ICD-10 Finland

Rotator cuff syndrome

4.3

137.9

580

1316

J96.1

ICD-10 Finland

Chronic respiratory failure

17.0

137.2

232

125

L88

ICPC

Rheumatoid/seropositive arthritis

85.1

136.8

161

M19.0

ICD-10 Finland

Primary arthrosis of other joints

19.6

136.3

219

102

C10AA01

ATC

simvastatin; oral

2.7

136.2

1250

5110

R02

ICPC

Shortness of breath/dyspnoea

5.6

136.1

439

746

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

3.5

135.1

743

2131

Z3231

NOMESCO Finland

Registered nurse

3.1

134.7

913

3061

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

258.8

133.9

144

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

3.5

132.6

733

2108

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

60.9

132.4

163

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

50.4

132.3

168

ACC51

NOMESCO Finland

Release of median nerve

145.1

130.8

146

J45.1

ICD-10 Finland

Nonallergic asthma

7.1

130.2

349

463

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.7

130.0

1207

4937

ZXA00

NOMESCO Finland

Right side

3.3

129.6

803

2513

ZXE10

NOMESCO Finland

More than one and less than three hours

2.7

129.3

1154

4607

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

3.6

129.1

686

1906

ZXE00

NOMESCO Finland

One hour or less

2.6

128.9

1280

5440

48499

ICD-8 Finland

Acute interstitial pneumonia

+∞

128.5

130

H02AB07

ATC

prednisone; oral

4.0

127.9

593

1465

L01XE31

ATC

[U] nintedanib; oral

+∞

124.5

126

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

87.1

124.4

146

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

27.1

123.7

180

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

291.5

123.5

132

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

1128.8

123.4

127

SPAT1263

SPAT

Sampling

2.6

123.3

1177

4857

M04AA01

ATC

allopurinol; systemic

5.2

123.2

427

785

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

5.4

122.6

412

731

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

3.1

122.6

813

2660

L28

ICPC

Limited function/disability (L)

5.7

120.7

384

638

B01AB05

ATC

enoxaparin; parenteral

3.0

119.5

879

3078

S06.0

ICD-10 Finland

Concussion

15.6

116.9

204

119

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

129.6

116.2

131

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

4.3

116.0

490

1104

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

116.6

115.1

131

J01CA04

ATC

amoxicillin; systemic

2.4

114.3

2477

15377

B01AA03

ATC

warfarin; systemic

3.5

113.7

624

1762

XG466

NOMESCO Finland

Sleep oxymetry

23.1

113.1

172

NF1AA

NOMESCO Finland

Hip X-ray examination

13.7

112.6

207

137

Z94.2

ICD-10 Finland

Lung transplant status

1027.4

112.5

116

I25.1

ICD-10 Finland

Atherosclerotic heart disease

3.2

112.5

693

2135

J45.0

ICD-10 Finland

Predominantly allergic asthma

5.7

112.4

354

579

A10BB12

ATC

glimepiride; oral

156.1

110.8

123

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

3.9

110.2

523

1307

R03BA08

ATC

ciclesonide; inhalant

5.4

109.0

361

626

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

5.8

108.8

339

546

M01AH05

ATC

etoricoxib; oral

2.3

108.7

1556

7815

A02BC03

ATC

lansoprazole; oral

2.8

108.6

881

3255

I10

ICD-10 Finland

Essential (primary) hypertension

2.3

108.3

1569

7921

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

5.9

108.3

332

524

N02AA05

ATC

oxycodone; systemic

4.1

108.3

478

1118

J01FF01

ATC

clindamycin; systemic

2.8

108.0

844

3044

A10BK03

ATC

empagliflozin; oral

152.1

107.9

120

WX320

NOMESCO Finland

Spinalanesthesy

3.5

107.1

578

1604

J84.0

ICD-10 Finland

Alveolar and parietoalveolar conditions

+∞

106.6

108

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

972.4

106.6

110

ZX120

NOMESCO Finland

Intravenous

4.4

105.8

429

924

UJF32

NOMESCO Finland

Coloscopy

2.9

105.7

783

2723

GDG10

NOMESCO Finland

Bilateral transplantation of lung

954.2

104.6

108

127

Kela drug reimbursment

Transplant complication

29.4

104.1

148

S18

ICPC

Laceration/cut

2.5

103.8

1128

4899

L04AD01

ATC

ciclosporin; systemic

23.4

103.8

157

J01MA02

ATC

ciprofloxacin; systemic

2.4

103.6

1192

5333

R03AK07

ATC

formoterol and budesonide; inhalant

3.1

103.6

663

2086

J01DA01

ATC

[U] cefalexin; systemic

2.2

103.6

1907

10686

XF400

NOMESCO Finland

ECG with 12 standard connections

3.5

103.1

567

1594

WX408

NOMESCO Finland

General anesthesy, balanced

2.7

103.0

885

3368

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

935.9

102.6

106

WX722

NOMESCO Finland

PEEP

15.7

102.6

178

102

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

14.1

101.3

184

118

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

7.2

101.3

265

336

R03AK08

ATC

formoterol and beclometasone; inhalant

9.8

101.2

219

203

M54.4

ICD-10 Finland

Lumbago with sciatica

5.4

101.0

336

584

ZXA05

NOMESCO Finland

Left side

2.9

100.6

717

2423

C10AA05

ATC

atorvastatin; oral

2.5

100.5

1034

4346

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

3.1

100.5

668

2152

B01AC04

ATC

clopidogrel; oral

4.4

100.4

405

866

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.8

100.3

801

2907

R07.4

ICD-10 Finland

Chest pain, unspecified

2.9

100.3

742

2568

H02AB04

ATC

methylprednisolone; systemic

3.6

99.7

524

1418

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.4

99.7

1149

5120

A10AE05

ATC

insulin detemir; parenteral

139.0

98.2

110

WX892

NOMESCO Finland

Monitored bed care

5.3

97.2

327

575

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

31.4

95.9

134

L03

ICPC

Low back symptom/complaint

3.3

95.6

561

1649

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.4

93.7

382

823

A28

ICPC

Limited function/disability NOS

4.6

93.2

355

714

N05CF01

ATC

zopiclone; oral

2.5

92.3

963

4043

N06AA09

ATC

amitriptyline; systemic

6.4

92.3

264

379

M10.9

ICD-10 Finland

Gout, unspecified

10.5

92.2

192

165

R03DC03

ATC

montelukast; oral

3.3

91.7

524

1505

ZXD10

NOMESCO Finland

Scheduled procedure

2.3

91.4

1162

5385

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

102.0

90.2

104

NH3EA

NOMESCO Finland

Feet X-ray examination with load

73.5

90.2

108

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

17.1

90.0

151

R05

ICPC

Cough

2.8

89.5

674

2338

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

26.7

88.6

129

C09AA05

ATC

ramipril; oral

2.7

88.3

725

2652

Z2221

NOMESCO Finland

Medical doctor

2.5

87.1

890

3677

G44.2

ICD-10 Finland

Tension-type headache

5.6

87.1

278

458

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

790.5

86.8

J01FA10

ATC

azithromycin; systemic

2.1

86.2

1712

9590

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

7.1

86.1

227

290

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.4

85.9

893

3719

R03BA02

ATC

budesonide; inhalant

3.0

85.8

588

1915

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

85.7

M01AH01

ATC

celecoxib; oral (coxibs)

3.5

85.7

456

1236

C08CA01

ATC

amlodipine; oral

2.4

85.0

935

4003

A10BH05

ATC

linagliptin; oral

+∞

84.8

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

268.7

84.7

M01AE03

ATC

ketoprofen; systemic, rectal

2.3

84.6

1054

4797

WX110

NOMESCO Finland

Local anesthesy

2.0

84.4

1954

11613

N06AX11

ATC

mirtazapine; oral

2.5

83.8

814

3262

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.9

83.3

587

1944

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

136.4

82.9

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.8

82.5

621

2143

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

745.4

81.9

WX002

NOMESCO Finland

Sedation and analgesia

2.9

81.8

570

1872

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.2

81.8

1154

5546

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

3.5

81.5

434

1175

WX780

NOMESCO Finland

Remote monitoring CPAP

193.3

80.5

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

7.3

80.2

208

259

M20.1

ICD-10 Finland

Hallux valgus (acquired)

11.8

80.2

157

119

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

114.3

79.9

L01EX09

ATC

nintedanib; oral

+∞

79.8

R04.2

ICD-10 Finland

Haemoptysis

8.0

78.6

191

215

E0000UV

ATC

2.2

78.5

1144

5556

M03BX02

ATC

tizanidine; oral

2.0

78.4

1658

9391

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.5

78.3

768

3079

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

152.9

78.3

M01AC06

ATC

meloxicam; systemic, rectal

2.3

77.6

941

4194

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

12.5

77.6

148

106

M01AH02

ATC

rofecoxib; oral

3.9

77.4

351

829

M54.9

ICD-10 Finland

Dorsalgia, unspecified

6.1

77.3

227

336

R03BA01

ATC

beclometasone; inhalant

3.1

77.1

487

1492

A07AA02

ATC

nystatin; oral

5.4

77.0

251

423

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.8

76.9

562

1897

R4120

NOMESCO Finland

Occupational therapy

8.6

76.9

179

188

ZXA10

NOMESCO Finland

Bilateral

2.9

76.9

548

1819

R03BA05

ATC

fluticasone; inhalant

2.8

76.7

586

2034

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

4.1

75.9

330

750

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

75.8

M01AE02

ATC

naproxen; oral, rectal

2.0

75.7

1499

8231

SPAT1325

SPAT

Vaccination

2.3

75.4

923

4123

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

30.2

75.3

106

M01AB05

ATC

diclofenac; systemic, rectal

2.0

75.1

1854

11073

M01CB01

ATC

sodium aurothiomalate; parenteral

237.5

75.0

D07AC01

ATC

betamethasone; topical

2.2

74.7

1013

4739

ZXD05

NOMESCO Finland

Urgent procedure

2.3

74.5

867

3778

L15

ICPC

Knee symptom/complaint

3.1

74.3

462

1397

J47

ICD-10 Finland

Bronchiectasis

13.2

73.9

137

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

6.4

73.8

210

298

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

7.5

73.5

186

223

WX723

NOMESCO Finland

CPAP therapy

105.3

73.2

R51.80

ICD-10 Finland

Headache

4.4

73.0

292

612

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

16.9

72.6

122

R01AD09

ATC

mometasone; nasal

2.1

72.6

1212

6182

L17

ICPC

Foot/toe symptom/complaint

2.7

72.5

594

2144

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

5.1

72.5

250

449

A10BD07

ATC

metformin and sitagliptin; systemic

+∞

71.9

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

2.4

71.8

744

3050

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

23.6

71.2

107

SPAT1229

SPAT

Assessment of need for aid

7.2

70.9

184

229

Z3229

NOMESCO Finland

Other healthcare associate professional

4.4

70.9

284

596

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

19.0

70.8

114

AN1

Coronary angiography

3.7

70.8

339

837

X59

ICD-10 Finland

Exposure to unspecified factor

3.0

70.5

468

1478

TPH07

NOMESCO Finland

Cathetrisation of artery

3.5

69.7

362

955

L04AB01

ATC

etanercept; parenteral

321.8

69.5

M01AX05

ATC

glucosamine; oral

3.2

69.3

413

1209

C01DA14

ATC

isosorbide mononitrate; oral

3.2

69.2

411

1200

J01FA09

ATC

clarithromycin; systemic

2.2

69.1

929

4303

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

9.5

69.1

151

142

M02AA07

ATC

piroxicam; topical

2.1

68.5

975

4626

E66.01

ICD-10 Finland

Obesity due to excess calories

7.7

68.5

170

198

R42

ICD-10 Finland

Dizziness and giddiness

2.9

68.2

478

1562

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.7

67.9

324

797

Z2446

NOMESCO Finland

Social worker

4.9

67.8

241

447

WW200

NOMESCO Finland

Immunization

8.3

67.5

160

173

R06AE07

ATC

cetirizine; oral

2.0

67.3

1209

6302

SPAT1249

SPAT

Treatment-related counselling outside office

2.1

67.3

1002

4841

SPAT1310

SPAT

Counselling related to known health issue

2.2

66.7

815

3604

A06AC01

ATC

ispaghula (psylla seeds); oral

2.5

66.4

638

2502

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

4.0

66.0

292

672

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

66.0

R53

ICD-10 Finland

Malaise and fatigue

2.9

65.6

447

1429

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.8

65.5

478

1597

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

36.8

65.5

L04AA01

ATC

[U] ciclosporin; systemic

25.6

65.4

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

38.2

65.3

A46

ICD-10 Finland

Erysipelas

3.3

65.2

363

1009

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

6.1

65.1

192

285

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

157.4

65.0

5150X

ICD-9 Finland

Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]

+∞

65.0

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

3.7

64.9

311

767

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.4

64.9

639

2538

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

127.7

64.8

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

31.6

64.8

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

4.4

64.3

255

529

TDM10

NOMESCO Finland

Puncture of maxillary antrum

7.1

64.1

168

212

A06AD11

ATC

lactulose; oral

3.1

64.0

404

1228

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

155.2

64.0

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

4.9

63.9

226

416

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

106.4

63.7

M01AX17

ATC

nimesulide; oral

2.4

63.6

626

2480

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.6

62.8

319

824

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.6

62.6

308

775

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

15.3

62.6

109

205

Kela drug reimbursment

Chronic hypertension

2.3

62.1

677

2823

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

+∞

62.0

A02BA02

ATC

ranitidine; systemic

2.5

61.8

557

2103

NE1AA

NOMESCO Finland

Pelvis X-ray examination

9.1

61.8

138

135

D64.9

ICD-10 Finland

Anaemia, unspecified

3.6

61.2

303

766

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

5.0

61.2

211

378

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

4.3

61.1

245

513

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.0

61.1

959

4699

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

34.6

61.0

N06AX21

ATC

duloxetine; oral

4.9

61.0

216

398

A01AB09

ATC

miconazole; local oral

3.8

61.0

286

691

SPAT1153

SPAT

Removal of sutures

2.2

60.9

776

3475

C08CA02

ATC

felodipine; oral

3.9

60.6

276

650

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.6

60.0

504

1827

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

+∞

60.0

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

+∞

60.0

ZXE20

NOMESCO Finland

More than three and less than five hours

2.8

59.8

429

1413

I50.0

ICD-10 Finland

Congestive heart failure

4.7

59.8

221

426

M05BA07

ATC

risedronic acid; oral

10.1

59.7

126

111

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

20.2

59.7

WZC30

NOMESCO Finland

Teaching

2.7

59.7

471

1648

ZX108

NOMESCO Finland

Inhalation

23.7

59.4

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

3.4

59.0

320

869

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

+∞

59.0

M79.0

ICD-10 Finland

Rheumatism, unspecified

42.1

59.0

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

28.3

58.9

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

272.5

58.8

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

2.5

58.8

521

1946

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

5.0

58.7

202

361

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.9

58.6

406

1309

SPAT1216

SPAT

Assessment of functional ability

3.4

58.6

311

831

M03BC01

ATC

orphenadrine (citrate); systemic

2.5

58.5

535

2031

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

4.1

58.4

247

544

J46

ICD-10 Finland

Status asthmaticus

11.7

58.4

114

L08

ICPC

Shoulder symptom/complaint

2.7

58.1

452

1564

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

3.7

58.1

281

696

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

75.4

58.0

SPAT1254

SPAT

Administration of medicine

3.3

57.7

318

872

L04AB04

ATC

adalimumab; parenteral

28.8

57.7

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

9.7

57.3

123

112

A10BB01

ATC

glibenclamide; oral

61.3

57.2

XX4BW

NOMESCO Finland

67.1

57.1

212

Kela drug reimbursment

Gout

+∞

57.1

R81

ICPC

Pneumonia

6.6

56.9

156

210

M79.1

ICD-10 Finland

Myalgia

3.7

56.8

276

686

R28

ICPC

Limited function/disability (R)

19.8

56.8

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

36.9

56.7

M81.9

ICD-10 Finland

Osteoporosis, unspecified

9.0

56.7

127

125

R60.0

ICD-10 Finland

Localized oedema

3.8

56.5

262

626

B01AF01

ATC

rivaroxaban; oral

3.9

56.5

254

591

M70.6

ICD-10 Finland

Trochanteric bursitis

4.2

56.4

235

510

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

512.7

56.3

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

512.7

56.3

M43.1

ICD-10 Finland

Spondylolisthesis

30.1

56.3

L13

ICPC

Hip symptom/complaint

3.4

56.1

304

824

SPAT1301

SPAT

No procedures

2.1

56.1

742

3363

UDH02

NOMESCO Finland

Rhinopharyngoscopy

4.4

56.0

222

459

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.3

56.0

318

893

C03DA01

ATC

spironolactone; oral

3.3

55.8

306

837

SAA03

NOMESCO Finland

Extended examination of mouth

1.9

55.7

1007

5175

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.9

55.4

1157

6266

M47.9

ICD-10 Finland

Spondylosis, unspecified

59.3

55.3

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

41.9

55.2

NG1DA

NOMESCO Finland

X-ray of knees

81.1

55.1

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

4.0

55.0

238

535

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

258.6

54.9

C07AB02

ATC

metoprolol; systemic

2.4

54.4

529

2067

C10AA03

ATC

pravastatin; oral

4.5

54.1

209

421

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.6

54.1

436

1538

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

+∞

54.1

G40.9

ICD-10 Finland

Epilepsy, unspecified

254.0

53.9

XF402

NOMESCO Finland

ECG with work load test

3.1

53.8

322

936

H25.1

ICD-10 Finland

Senile nuclear cataract

2.3

53.8

614

2597

XW000

NOMESCO Finland

Bone marrow biopsy

5.4

53.7

172

283

M01AB55

ATC

diclofenac, combinations; oral

5.1

53.6

181

316

P01AB01

ATC

metronidazole; oral, rectal

1.9

53.5

1062

5635

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

130.7

53.4

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

27.0

53.4

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

13.5

53.2

72410

ICD-8 Finland

Internal derangement of joint, Other shoulder derangement

+∞

53.1

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.1

53.1

319

932

XG474

NOMESCO Finland

Exhalation nntrogen oxide

7.5

52.7

132

156

M47.82

ICD-10 Finland

Other spondylosis, cervical region

19.7

52.4

N06AX16

ATC

venlafaxine; oral

3.1

52.4

326

976

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

21.9

52.3

XF600

NOMESCO Finland

Bloodpressure measurement

4.5

52.2

199

396

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

5.7

51.9

160

251

T89

ICPC

Diabetes insulin dependent

55.8

51.6

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

18.7

51.5

S97

ICPC

Chronic ulcer skin

6.6

51.4

140

187

A10BK01

ATC

dapagliflozin; oral

44.3

51.1

C10AX09

ATC

ezetimibe; oral

3.2

51.0

290

813

H03AA01

ATC

levothyroxine sodium; systemic

2.2

51.0

585

2473

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

240.2

51.0

J45.8

ICD-10 Finland

Mixed asthma

7.6

50.9

126

146

J20

ICD-10 Finland

Acute bronchitis

3.4

50.9

273

733

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.8

50.9

1470

8799

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

4.7

50.5

183

345

R06.2

ICD-10 Finland

Wheezing

5.7

50.5

155

242

A10AA02

ATC

101.0

50.4

E66.8

ICD-10 Finland

Other obesity

9.8

50.3

107

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

50.2

1686

10553

SPAT1260

SPAT

Consultation of another employee

2.5

50.2

432

1579

UJF30

NOMESCO Finland

Ileoscopy through colon

3.1

50.2

300

873

JN4BD

NOMESCO Finland

Extensive body CT

2.6

49.7

423

1534

A04

ICPC

Weakness/tiredness general

3.4

49.6

265

709

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.9

49.6

224

522

WX111

NOMESCO Finland

Local infiltration anesthesia

450.6

49.5

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

53.2

48.8

J43.9

ICD-10 Finland

Emphysema, unspecified

7.7

48.8

120

138

A01

ICPC

Pain general/multiple sites

5.0

48.7

167

297

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.5

48.6

154

250

L90

ICPC

Osteoarthrosis of knee

7.9

48.6

117

130

R03AC03

ATC

terbutaline; inhalant

2.6

48.5

396

1402

N06AB04

ATC

citalopram; systemic

2.3

48.5

522

2138

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

33.8

48.4

E000001

ATC

2.2

48.4

557

2353

R05FB02

ATC

cough suppressants and expectorants

1.8

48.3

1055

5739

M05BX04

ATC

denosumab; parenteral

4.8

48.2

172

319

J01FA15

ATC

telithromycin; oral

2.8

48.2

335

1076

WX872

NOMESCO Finland

Intensive care

4.1

48.1

202

441

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.5

47.9

240

611

N04BC05

ATC

pramipexole; oral

5.3

47.7

155

259

J45

ICD-10 Finland

Asthma

3.2

47.6

271

759

C08CA05

ATC

nifedipine; systemic

4.0

47.5

206

463

R01AD12

ATC

fluticasone furoate; nasal

2.0

47.5

753

3643

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.9

47.4

209

477

Z50.1

ICD-10 Finland

Other physical therapy

6.8

47.4

127

166

R99

ICPC

Respiratory disease other

13.2

47.2

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

12.4

47.0

NHK30

NOMESCO Finland

Osteotomy or rotation osteotomy of first metatarsal or tarsal bone

115.2

46.7

R06.5

ICD-10 Finland

Mouth breathing

4.1

46.7

196

428

SPAT1255

SPAT

Intravenous administration of medicine

4.1

46.6

197

433

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.6

46.6

387

1383

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

424.1

46.5

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

24.1

46.5

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.3

45.9

468

1861

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

45.9

1872

12269

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

4.1

45.8

193

423

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

415.2

45.6

R01AD08

ATC

fluticasone; nasal

2.0

45.3

755

3713

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

12.9

45.3

M34.1

ICD-10 Finland

CR(E)ST syndrome

+∞

45.2

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.0

45.1

678

3201

N05BA04

ATC

oxazepam; oral

2.1

45.1

601

2703

R03AC13

ATC

formoterol; inhalant

4.1

44.9

187

405

Z71.8

ICD-10 Finland

Other specified counselling

2.1

44.8

573

2530

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

6.2

44.7

128

183

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

3.4

44.6

237

631

N17.9

ICD-10 Finland

Acute renal failure, unspecified

6.0

44.5

130

191

I20.99

ICD-10 Finland

Angina pectoris, unspecified

4.3

44.4

175

360

J02AC01

ATC

fluconazole; systemic

1.8

44.3

987

5369

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

+∞

44.2

K02.1

ICD-10 Finland

Caries of dentine

1.7

44.2

1458

8950

A10AE06

ATC

insulin degludec; parenteral

208.4

44.2

XX9XE

NOMESCO Finland

Other ultrasound examination

36.7

44.1

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

27.5

44.0

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

65.9

43.9

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

28.4

43.7

D07AB02

ATC

hydrocortisone butyrate; topical

1.9

43.7

749

3716

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.2

43.4

255

730

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

4.5

43.3

164

324

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

+∞

43.3

TNG10

NOMESCO Finland

Puncture of knee

+∞

43.3

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

8.9

43.2

M09AX01

ATC

hyaluronic acid; parenteral

9.2

43.1

H04.10

ICD-10 Finland

Dry eye syndrome

3.1

43.0

264

780

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.6

42.9

158

303

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

6.9

42.9

113

144

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

5.3

42.6

139

234

XCK10

NOMESCO Finland

Photography of fundus of eye

3.5

42.1

212

541

UDQ12

NOMESCO Finland

Flexible laryngoscopy

4.5

42.0

160

318

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.7

42.0

1360

8266

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.3

41.8

230

628

E66.00

ICD-10 Finland

Metabolic syndrome

6.5

41.8

115

156

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

15.3

41.8

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.7

41.7

308

1024

M35.3

ICD-10 Finland

Polymyalgia rheumatica

9.6

41.6

N05AH04

ATC

quetiapine; oral

2.6

41.4

332

1159

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.7

41.4

309

1034

N03AE01

ATC

clonazepam; systemic

5.3

41.3

134

224

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

+∞

41.3

B01AF02

ATC

apixaban; oral

3.2

41.3

231

639

Angiography of the heart and coronary arteries

4.1

41.3

172

373

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

20.7

41.2

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.8

41.2

298

977

D86.0

ICD-10 Finland

Sarcoidosis of lung

10.7

41.0

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

8.7

41.0

N05CD07

ATC

temazepam; oral

2.5

40.7

343

1231

C09CA01

ATC

losartan; oral

2.0

40.7

590

2737

A03

ICPC

Fever

2.4

40.4

389

1500

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

+∞

40.3

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.7

40.3

297

987

R96

ICPC

Asthma

3.3

40.2

224

617

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

130.1

40.1

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

3.0

40.1

256

775

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

5.5

39.9

126

204

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

362.3

39.7

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

362.3

39.7

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

39.7

1199

7111

207

Kela drug reimbursment

Chronic arrhythmias

2.5

39.4

338

1224

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

14.2

39.4

R07.3

ICD-10 Finland

Other chest pain

3.2

39.4

224

627

M45

ICD-10 Finland

Ankylosing spondylitis

53.2

39.3

A10BJ06

ATC

semaglutide; parenteral

+∞

39.3

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

+∞

39.3

A10AA01

ATC

97.6

39.1

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

3.0

39.0

242

719

M03BC51

ATC

orphenadrine, combinations; systemic

1.9

38.9

649

3170

XQ800

NOMESCO Finland

Prick test

3.3

38.8

210

567

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.6

38.7

303

1042

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.8

38.6

853

4590

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

7.6

38.5

110

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

7.1

38.5

122

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

52.1

38.4

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

182.0

38.4

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

+∞

38.3

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

+∞

38.3

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

9.3

38.2

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

15.7

38.2

GX1K5

NOMESCO Finland

Diffusion capacity

78.1

38.1

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.8

38.0

173

406

B02.9

ICD-10 Finland

Zoster without complication

3.6

37.9

186

465

M35.1

ICD-10 Finland

Other overlap syndromes

344.7

37.7

H02AB09

ATC

hydrocortisone; systemic

8.8

37.7

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

4.3

37.7

149

307

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.6

37.5

306

1077

JN4AD

NOMESCO Finland

Body CT examination

2.7

37.5

277

920

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

51.0

37.5

G56.2

ICD-10 Finland

Lesion of ulnar nerve

18.7

37.5

I25.2

ICD-10 Finland

Old myocardial infarction

3.3

37.5

200

534

D07AC13

ATC

mometasone; topical

1.8

37.4

789

4177

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

+∞

37.3

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

+∞

37.3

A10BG03

ATC

pioglitazone; oral

+∞

37.3

9211

FHL

Exploration or removal of diskusprolapse

+∞

37.3

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

121.3

37.3

N18.8

ICD-10 Finland

Other chronic renal failure

8.4

37.2

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

3.3

37.0

198

530

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.4

36.9

194

512

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

4.4

36.8

143

290

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

335.9

36.8

X58

ICD-10 Finland

Exposure to other specified factors

2.6

36.7

304

1078

-1

NOMESCO Finland

1.8

36.7

805

4314

WX725

NOMESCO Finland

Noninvasive ventilation

4.1

36.6

153

333

NA1AD

NOMESCO Finland

Cervical spine CT examination

8.5

36.5

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

5.5

36.4

114

183

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

+∞

36.4

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.8

36.3

256

826

J67.9

ICD-10 Finland

Hypersensitivity pneumonitis due to unspecified organic dust

118.4

36.3

XF404

NOMESCO Finland

Ambulatory ECG

2.9

36.3

235

718

A41.9

ICD-10 Finland

Sepsis, unspecified

5.0

36.2

122

213

M54.3

ICD-10 Finland

Sciatica

6.8

36.2

124

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.6

36.2

178

446

L86

ICPC

Back syndrome with radiating pain

5.9

36.1

106

157

NBG10

NOMESCO Finland

Acromioplastia

24.2

35.9

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

3.7

35.8

167

400

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

3.8

35.8

164

387

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

327.1

35.8

M81.4

ICD-10 Finland

Drug-induced osteoporosis

327.1

35.8

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

5.3

35.8

116

194

TK800

NOMESCO Finland

Hemodialysis

8.6

35.7

R13

ICD-10 Finland

Dysphagia

3.7

35.6

164

389

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.9

35.5

668

3393

L01

ICPC

Neck symptom/complaint

2.6

35.5

275

939

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.2

35.5

199

551

M01AE01

ATC

ibuprofen; systemic, rectal

1.7

35.4

2597

19223

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

+∞

35.4

85000

ICD-8 Finland

Concussion, Current or unspecified

+∞

35.4

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

115.5

35.4

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

88.8

35.3

WX204

NOMESCO Finland

Axillary plexus blockaced

7.3

35.3

107

R03DA04

ATC

theophylline; systemic, rectal

2.9

35.2

233

721

R03AK11

ATC

formoterol and fluticasone; inhalant

6.2

35.2

100

142

ZY010

NOMESCO Finland

Hospital outpatient

4.8

35.1

124

228

WZA90

NOMESCO Finland

Other doctors statement

2.0

35.0

512

2369

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

5.4

34.8

111

182

M54.1

ICD-10 Finland

Radiculopathy

10.1

34.8

M20.2

ICD-10 Finland

Hallux rigidus

47.7

34.7

J31.0

ICD-10 Finland

Chronic rhinitis

3.2

34.7

198

555

J96.0

ICD-10 Finland

Acute respiratory failure

10.9

34.6

JN3AD

NOMESCO Finland

Abdominal CT examination

3.1

34.6

209

610

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

3.8

34.6

157

368

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

36.3

34.5

R52.9

ICD-10 Finland

Pain, unspecified

3.5

34.4

175

450

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

+∞

34.4

WZA10

NOMESCO Finland

Long statement of health and health related matters

13.1

34.4

L40.5

ICD-10 Finland

Arthropathic psoriasis

31.4

34.1

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.3

33.9

182

488

SPAT1312

SPAT

General health counselling

1.8

33.8

746

3987

R03AC12

ATC

salmeterol; inhalant

3.4

33.8

174

452

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

4.7

33.8

122

230

SPAT1097

SPAT

Recording of ECG

2.3

33.7

339

1330

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.6

33.7

270

939

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.6

33.6

265

914

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

4.1

33.4

139

301

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

18.1

33.4

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

+∞

33.4

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

+∞

33.4

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

2.0

33.4

481

2208

M50.3

ICD-10 Finland

Other cervical disc degeneration

38.1

33.3

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

26.0

33.2

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

30.7

33.2

Z01.2

ICD-10 Finland

Dental examination

1.7

33.1

1016

5978

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

7.2

33.1

102

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.5

33.1

167

427

W19

ICD-10 Finland

Unspecified fall

3.1

33.1

198

574

G04CA02

ATC

tamsulosin; oral

1.9

33.0

578

2854

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

8.2

33.0

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

4.4

32.9

125

248

5BA08

NOMESCO Finland

27.2

32.9

N03AF01

ATC

carbamazepine; oral, rectal

5.2

32.9

107

180

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

300.7

32.9

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

4.6

32.7

119

226

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.5

32.7

287

1048

J01EA01

ATC

trimethoprim; systemic

1.9

32.6

575

2845

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

155.7

32.6

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

16.8

32.6

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

4.1

32.5

135

292

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

106.7

32.5

UKC02

NOMESCO Finland

Cystoscopy

2.1

32.5

387

1642

L16

ICPC

Ankle symptom/complaint

3.0

32.4

196

573

C08CA13

ATC

lercanidipine; oral

2.5

32.4

268

949

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

3.6

32.3

158

394

XJC10

NOMESCO Finland

Oesophageal pH monitoring

19.3

32.3

A02BA04

ATC

nizatidine; systemic

2.8

32.3

221

700

L29

ICPC

Musculoskeletal sympt/complt other

3.5

32.2

159

400

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.3

32.1

176

479

UDC00

NOMESCO Finland

Ear microscopy

3.0

32.1

195

571

SPAT1211

SPAT

Application of soft bandage

3.0

32.1

197

579

N05BA01

ATC

diazepam; systemic, rectal

2.4

32.0

307

1175

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.8

31.9

673

3537

R74

ICPC

Upper respiratory infection acute

1.8

31.9

614

3131

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

291.9

31.9

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.6

31.9

1474

9604

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.2

31.9

180

501

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.7

31.8

234

775

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

7.3

31.8

R55

ICD-10 Finland

Syncope and collapse

2.7

31.8

232

762

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

6.5

31.8

118

GD2SN

NOMESCO Finland

Lung ventilation SPECT

27.9

31.8

R05FA02

ATC

opium derivatives and expectorants; systemic

1.6

31.7

1053

6312

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

56.2

31.7

B01AB04

ATC

dalteparin; parenteral

4.1

31.6

132

287

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

103.8

31.6

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.2

31.5

338

1365

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

24.9

31.5

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

+∞

31.4

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

+∞

31.4

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

+∞

31.4

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

10.1

31.4

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

9.3

31.4

J05AB11

ATC

valaciclovir; oral

2.2

31.3

364

1526

C10AA07

ATC

rosuvastatin; oral

1.9

31.3

549

2708

D07XC01

ATC

betamethasone, combinations; topical

2.2

31.2

338

1371

R11

ICD-10 Finland

Nausea and vomiting

3.3

31.2

171

466

M54.6

ICD-10 Finland

Pain in thoracic spine

4.4

31.1

119

238

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

23.5

31.0

NF1DA

NOMESCO Finland

X-ray of hips

48.2

30.9

J01CE02

ATC

phenoxymethylpenicillin; oral

1.5

30.9

1878

13003

NG2AA

NOMESCO Finland

Patella X-ray examination

33.1

30.9

R20.2

ICD-10 Finland

Paraesthesia of skin

4.2

30.9

124

260

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

10.4

30.9

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

5.6

30.8

150

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.8

30.8

644

3372

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.4

30.8

160

419

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

6.9

30.8

101

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

30.7

413

1841

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

147.0

30.7

N03AF02

ATC

oxcarbazepine; oral

18.5

30.7

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.3

30.6

119

242

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

3.1

30.5

177

500

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

+∞

30.5

73799

ICD-8 Finland

Hallux valgus and varus

+∞

30.5

ZX140

NOMESCO Finland

Intra articular

+∞

30.5

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

+∞

30.5

7170A

ICD-9 Finland

Internal derangement of knee, Old bucket handle tear of medial meniscus

+∞

30.5

R5599

NOMESCO Finland

Other rehabilitation service

10.0

30.3

M54

ICD-10 Finland

Dorsalgia

2.7

30.3

217

707

M54.2

ICD-10 Finland

Cervicalgia

4.5

30.2

114

225

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

3.6

30.1

145

357

XA800

NOMESCO Finland

Neuropsychological investigation

7.4

30.1

GX1D5

NOMESCO Finland

Flow volume spirometry

274.4

30.0

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

11.5

29.9

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

13.4

29.9

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

14.0

29.8

XA402

NOMESCO Finland

ENMG

16.1

29.8

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

142.6

29.7

WX721

NOMESCO Finland

Oxygen concentrator therapy

142.6

29.7

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.3

29.6

156

413

M05BB03

ATC

alendronic acid and colecalciferol; oral

6.7

29.5

101

NHG70

NOMESCO Finland

Arthroplasty of first tarsometatarsal joint

+∞

29.5

L04AA24

ATC

abatacept; parenteral

+∞

29.5

L12

ICPC

Hand/finger symptom/complaint

2.4

29.3

275

1041

R29

ICPC

Respiratory symptom/complaint other

3.2

29.3

164

453

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

4.6

29.1

107

206

EBA00

NOMESCO Finland

Extraction of tooth

1.7

29.1

770

4320

A10BJ02

ATC

liraglutide; parenteral

270.0

29.0

NDL52

NOMESCO Finland

Tenosynovectomy of hand

270.0

29.0

I20.09

ICD-10 Finland

Unstable angina

3.6

28.8

139

343

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

8.8

28.8

K90

ICPC

Stroke/cerebrovascular accident

73.5

28.7

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

95.1

28.7

G43.9

ICD-10 Finland

Migraine, unspecified

8.1

28.7

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

13.8

28.7

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.5

28.6

245

883

M02AA10

ATC

ketoprofen; topical

2.1

28.5

352

1512

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

28.5

M33.2

ICD-10 Finland

Polymyositis

+∞

28.5

S22.3

ICD-10 Finland

Fracture of rib

3.2

28.4

159

438

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

5.1

28.4

162

ZXD20

NOMESCO Finland

Day surgery

2.2

28.2

302

1217

P06

ICPC

Sleep disturbance

2.9

28.2

180

544

L02

ICPC

Back symptom/complaint

3.0

28.2

170

494

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.7

28.2

129

305

C09AA02

ATC

enalapril; systemic

1.9

28.1

437

2056

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

4.4

28.1

107

214

M01CB03

ATC

auranofin; oral

71.4

27.8

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

35.5

27.7

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.2

27.7

156

433

GDA10

NOMESCO Finland

Biopsy of lung

28.1

27.7

R04.0

ICD-10 Finland

Epistaxis

3.0

27.6

173

517

J05AB01

ATC

aciclovir; systemic

1.8

27.6

519

2614

WX720

NOMESCO Finland

Own respiration

4.1

27.6

113

242

Z51.5

ICD-10 Finland

Palliative care

2.8

27.6

190

604

R52.2

ICD-10 Finland

Other chronic pain

8.2

27.6

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

3.5

27.6

138

351

L03.0

ICD-10 Finland

Cellulitis of finger and toe

3.3

27.6

149

402

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

+∞

27.5

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

+∞

27.5

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

+∞

27.5

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

4.0

27.4

117

260

M22.4

ICD-10 Finland

Chondromalacia patellae

24.7

27.4

M54.8

ICD-10 Finland

Other dorsalgia

5.9

27.3

119

M10

ICD-10 Finland

Gout

4.6

27.3

100

192

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.5

27.3

136

345

NBT60

NOMESCO Finland

Forcible manipulation of humeroscapular joint

43.2

27.3

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.8

27.3

542

2781

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.6

27.2

129

314

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

8.4

27.2

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

251.8

27.1

TAB00

NOMESCO Finland

Lumbar puncture

6.4

27.0

101

RK320

NOMESCO Finland

16.3

27.0

L95

ICPC

Osteoporosis

5.1

26.9

153

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

69.2

26.8

RS123

NOMESCO Finland

89.3

26.8

S29

ICPC

Skin symptom/complaint other

2.0

26.7

371

1672

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

24.1

26.6

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

26.5

767

4392

XG460

NOMESCO Finland

Short time oxymetry

6.0

26.5

110

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

10.7

26.5

B01AC07

ATC

dipyridamole; systemic

4.5

26.5

190

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

4.5

26.5

194

7350A

ICD-9 Finland

Acquired deformities of toe, Hallux valgus (acquired)

+∞

26.5

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

+∞

26.5

C03AA03

ATC

hydrochlorothiazide; oral

2.7

26.5

190

617

SPAT1104

SPAT

Monitoring of emergency patient

3.1

26.5

152

429

L89

ICPC

Osteoarthrosis of hip

11.0

26.4

N06AA12

ATC

doxepin; systemic

3.5

26.4

130

327

Z00.0

ICD-10 Finland

General medical examination

1.9

26.3

423

2013

N30.0

ICD-10 Finland

Acute cystitis

2.3

26.3

262

1018

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

3.1

26.3

154

439

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.2

26.3

149

416

KMAK

NOMESCO Finland

1.5

26.3

1283

8344

SPAT1053

SPAT

Memory test

2.4

26.3

239

890

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

7.7

26.2

N05CF02

ATC

zolpidem; oral

1.9

26.1

403

1889

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

6.4

26.1

9271

FHL

Hallux surgery

242.8

26.1

N80.1

ICD-10 Finland

Endometriosis of ovary

242.8

26.1

A10BH02

ATC

vildagliptin; oral

242.8

26.1

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

242.8

26.1

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

10.2

25.9

R4190

NOMESCO Finland

Nutritional therapy

3.7

25.9

118

278

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

125.2

25.9

318

Kela drug reimbursment

Teriparatide

125.2

25.9

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.4

25.9

191

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

86.4

25.9

SPAT1094

SPAT

Continuous Positive Airway Pressure

86.4

25.9

GD1UN

NOMESCO Finland

Lung circulation SPECT

23.5

25.7

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.8

25.6

113

259

A01AB04

ATC

amphotericin B; local oral

3.2

25.6

139

377

XX3DW

NOMESCO Finland

Time consuming IT work

2.1

25.6

321

1388

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

7.1

25.6

R04

ICPC

Breathing problem other

5.1

25.5

144

M31.3

ICD-10 Finland

Wegener granulomatosis

+∞

25.5

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

+∞

25.5

D07AD01

ATC

clobetasol; topical

1.9

25.5

398

1874

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

40.7

25.5

N19

ICD-10 Finland

Unspecified kidney failure

4.9

25.4

152

B01AX06

ATC

[U] rivaroxaban; oral

24.6

25.4

N07BA03

ATC

varenicline; oral

3.2

25.4

142

391

N39.4

ICD-10 Finland

Other specified urinary incontinence

3.1

25.4

149

426

L05

ICPC

Flank/axilla symptom/complaint

3.4

25.3

129

333

2AX04

NOMESCO Finland

46.1

25.3

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

5.6

25.2

121

TQW40

NOMESCO Finland

Remowal of suture of skin

2.7

25.2

186

616

M65.3

ICD-10 Finland

Trigger finger

5.8

25.2

111

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

25.2

454

2250

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

7.0

25.1

N80.0

ICD-10 Finland

Endometriosis of uterus

233.8

25.1

I50.1

ICD-10 Finland

Left ventricular failure

3.3

25.1

131

345

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

11.6

25.0

D07AB08

ATC

desonide; topical

2.2

25.0

275

1121

N06AB03

ATC

fluoxetine; oral

2.2

25.0

284

1175

G45.3

ICD-10 Finland

Amaurosis fugax

120.8

25.0

XPX04

NOMESCO Finland

Angioscopy

120.8

25.0

N03AX09

ATC

lamotrigine; oral

5.2

24.9

137

TKC20

NOMESCO Finland

Catheterisation of bladder

2.8

24.7

173

555

XG405

NOMESCO Finland

Education on PEF monitoring

7.4

24.7

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

17.3

24.6

M01AX01

ATC

nabumetone; oral

4.5

24.6

177

E66.9

ICD-10 Finland

Obesity, unspecified

8.4

24.6

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

16.1

24.6

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

11.6

24.6

M87.0

ICD-10 Finland

Idiopathic aseptic necrosis of bone

+∞

24.5

J99.0*M05.1

ICD-10 Finland

Rheumatoid lung disease

+∞

24.5

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

+∞

24.5

5183A

ICD-9 Finland

Other diseases of lung, Pulmonary eosinophilia

+∞

24.5

WX882

NOMESCO Finland

High dependency care

4.9

24.5

147

J01DA06

ATC

[U] cefuroxime; systemic

1.9

24.5

385

1816

K29.7

ICD-10 Finland

Gastritis, unspecified

4.4

24.5

182

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.5

24.4

119

297

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

24.4

594

3231

A02BA03

ATC

famotidine; systemic

3.4

24.4

125

325

P20

ICPC

Memory disturbance

2.9

24.3

160

495

WZA00

NOMESCO Finland

Short statement of of health and health related matters

3.5

24.3

119

298

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

9.6

24.2

R1250

NOMESCO Finland

Evaluation of functional capability

9.6

24.2

GAA31

NOMESCO Finland

Thoracoscopy

25.2

24.2

M01AB01

ATC

indometacin; systemic, rectal

2.7

24.2

171

553

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

3.2

24.2

136

377

NDG30

NOMESCO Finland

Fusion of wrist, total

224.8

24.1

H02BX01

ATC

methylprednisolone, combinations; systemic

3.6

24.1

113

273

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

3.4

24.1

124

323

J12.8

ICD-10 Finland

Other viral pneumonia

9.9

24.1

H05AA02

ATC

teriparatide; parenteral

116.5

24.0

NHL68

NOMESCO Finland

Tenodesis, shortening or lengthening of tendon of foot

116.5

24.0

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.9

24.0

103

231

R06AX27

ATC

desloratadine; oral

1.7

24.0

611

3366

M19.2

ICD-10 Finland

Other secondary arthrosis

80.6

24.0

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

80.6

24.0

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

80.6

24.0

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

34.5

23.9

5AB14

NOMESCO Finland

34.5

23.9

G51.0

ICD-10 Finland

Bell palsy

26.7

23.9

A12BA01

ATC

potassium chloride; oral

3.7

23.7

108

255

N06AB10

ATC

escitalopram; oral

1.9

23.7

375

1773

M72.0

ICD-10 Finland

Palmar fascial fibromatosis [Dupuytren]

9.2

23.7

SPAT1215

SPAT

Assessment of need for medical rehabilitation

4.9

23.6

142

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.8

23.6

156

484

M34.0

ICD-10 Finland

Progressive systemic sclerosis

+∞

23.6

M33.1

ICD-10 Finland

Other dermatomyositis

+∞

23.6

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

+∞

23.6

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

+∞

23.6

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

+∞

23.6

C02AC05

ATC

moxonidine; oral

4.8

23.6

150

A11

ICPC

Chest pain NOS

2.8

23.5

165

530

M05BA06

ATC

ibandronic acid; systemic

6.2

23.4

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

5.1

23.4

129

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

9.7

23.4

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

5.6

23.3

108

L04AB06

ATC

golimumab; parenteral

50.1

23.3

J01FA01

ATC

erythromycin; systemic

2.0

23.2

324

1460

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.3

23.2

180

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.9

23.2

356

1664

NHG26

NOMESCO Finland

Fusion between bones of ankle or ankle and foot

215.7

23.2

N03AX14

ATC

levetiracetam; systemic

13.7

23.1

Z01.9

ICD-10 Finland

Special examination, unspecified

3.2

23.1

125

339

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

77.7

23.0

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1233

2779

3.92

320.78

2.9

2.0

30.1

30.4

0.66

1208

2710

(3035350) Ketones [Presence] in Urine by Test strip

2800

10522

2.96

319.13

4.9

2.6

estimate

0.0

1.08

766

1800

(3020630) Protein [Mass/volume] in Serum or Plasma

832

1384

5.04

315.45

2.3

3.1

g/l

66.0

65.8

0.28

777

1259

(3008152) Bicarbonate [Moles/volume] in Arterial blood

726

1080

5.55

310.24

8.9

6.5

mmol/l

25.1

24.6

2.06

693

1001

(3001604) Monocytes [#/volume] in Blood

4064

10241

8.43

307.65

12.1

4.5

e9/l

0.7

0.6

35.28

3727

8456

(3039162) Centromere protein B Ab [Units/volume] in Serum

312

115

21.12

307.65

1.3

1.1

u/ml

55.0

4.8

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1460

3462

3.87

307.65

7.0

3.7

mmol/l

0.8

3.48

1372

3262

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2569

8419

3.35

307.65

2.9

1.8

nmol/l

77.9

78.7

0.59

2387

7421

(3015171) Extractable nuclear Ab [Units/volume] in Serum

818

369

19.00

307.65

1.3

1.1

u/ml

2.1

0.7

1.22

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

670

333

16.73

307.65

2.4

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

541

226

19.44

307.65

1.8

1.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2216

7057

3.20

307.65

5.5

3.2

u/l

33.9

38.9

0.96

2124

6731

(3003396) Base excess in Arterial blood by calculation

1481

2216

6.37

307.65

9.6

7.4

mmol/l

1.4

0.9

3.03

1231

1772

(3023368) Bacteria identified in Blood by Culture

2568

5581

5.49

307.65

6.1

3.8

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

530

174

24.71

307.65

1.5

1.1

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3340

9958

4.76

307.65

9.9

5.0

mmol/l

1.2

6.78

3150

8861

(3018010) Neutrophils/100 leukocytes in Blood

3813

10013

6.92

307.65

12.4

4.5

60.1

56.9

41.58

3732

9260

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1267

2689

4.21

307.65

2.9

1.9

g/l

2.3

0.32

1181

2494

(3013115) Eosinophils [#/volume] in Blood

4125

10667

8.46

307.65

13.0

4.7

e9/l

0.2

12.02

3830

8971

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

824

429

16.46

307.65

2.4

1.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

386

207

14.69

307.65

1.4

1.1

u/ml

58.1

28.0

1.40

(3042631) Mycobacterium sp identified in Specimen

549

287

15.54

307.65

3.0

2.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

599

248

19.84

307.65

1.4

1.1

u/ml

13.2

3.5

2.35

134

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

808

1101

6.16

307.65

11.4

9.7

mmol/l

24.6

24.4

1.18

741

1033

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1713

4645

3.49

307.65

2.6

1.9

mg/l

3.2

2.9

4.33

1512

3864

(3037692) Legionella sp identified in Specimen by Organism specific culture

323

40.69

307.65

2.0

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

834

449

15.95

307.65

2.4

1.5

—

(3017181) Myelocytes/100 leukocytes in Blood

1103

1548

6.31

307.65

6.0

3.5

0.8

0.9

0.79

398

487

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

641

727

7.22

307.65

2.5

1.8

ug/l

2.4

2.6

0.06

580

649

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

771

289

22.69

307.65

2.1

1.3

—

(3013707) Erythrocyte sedimentation rate by Westergren method

4336

15940

5.79

307.65

9.8

2.4

mm/h

17.7

12.0

76.53

4232

14169

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

944

428

19.40

307.65

1.8

1.4

titre

264.4

142.5

0.91

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

387

181

16.86

307.65

3.5

3.8

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

609

276

18.15

307.65

1.4

1.1

u/ml

42.4

26.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1867

2015

9.83

307.65

1.4

1.1

iu/ml

58.0

19.4

12.17

646

594

(3002030) Lymphocytes/100 leukocytes in Blood

3848

10237

6.93

307.65

13.0

4.6

24.9

27.9

44.48

3769

9402

(44806118)

418

188

17.63

307.65

2.7

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

980

941

9.12

307.65

2.2

2.1

g/l

1.2

1.5

1.98

914

838

(3020779) Urea [Moles/volume] in Serum or Plasma

956

1726

4.73

307.65

12.0

5.5

mmol/l

10.4

9.1

5.69

915

1655

(44790047)

418

188

17.63

307.65

2.7

1.3

—

(3019060) Gas panel - Arterial blood

1151

1116

9.34

307.65

4.9

4.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1815

4739

3.72

307.65

5.0

2.2

umol/l

2060.5

7586.8

6.87

1608

4128

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2112

4549

4.93

307.65

3.6

1.7

u/l

156.9

212.4

2.99

1994

4210

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1494

2215

6.45

307.65

9.6

7.4

kpa

5.0

5.1

1.33

1434

2107

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

708

271

21.93

307.65

1.9

1.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1146

2367

4.24

307.65

8.0

4.6

mmol/l

1.0

2.94

1068

2218

(3037522) Nuclear Ab [Titer] in Serum

2093

1610

14.86

307.65

1.5

1.2

titre

625.3

451.8

2.09

620

285

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

434

319

10.79

307.65

1.6

1.5

iu/ml

62.6

48.6

0.10

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

416

132.46

307.65

1.1

1.0

—

(3006315) Basophils [#/volume] in Blood

4071

10286

8.43

307.65

12.1

4.5

e9/l

0.0

9.84

3744

8488

(3027801) Oxygen [Partial pressure] in Arterial blood

1492

2212

6.45

307.65

9.6

7.4

kpa

10.2

13.1

69.94

1435

2104

(3036481) Cortisol [Moles/volume] in Serum or Plasma

909

1305

5.95

307.65

2.2

3.1

nmol/l

338.5

402.3

9.51

854

1228

(42870588) Differential panel, method unspecified - Blood

3291

6808

7.40

307.65

11.8

4.9

—

(3025159) Blasts/100 leukocytes in Blood

980

1375

6.17

307.65

6.0

3.5

0.2

0.4

0.21

333

389

(3004588) Protein electrophoresis panel - Serum or Plasma

738

939

6.53

307.65

2.1

2.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

510

435

9.41

307.65

1.8

2.0

mg/l

10.7

11.0

0.27

480

412

(3018095) Leukocytes [#/volume] in Urine

2466

8075

3.27

307.65

6.0

3.0

e6/l

101.7

121.9

0.33

1909

5474

(3016502) Oxygen saturation in Arterial blood

1244

1956

5.76

307.65

10.6

7.9

93.8

96.0

17.51

1204

1886

(3022948) Iron [Moles/volume] in Serum or Plasma

1347

2896

4.21

307.65

2.9

1.9

umol/l

11.7

13.5

13.60

1268

2684

(3032080) INR in Blood by Coagulation assay

2872

8747

3.98

307.65

11.9

7.6

inr

1.2

1.3

1.27

967

2416

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

604

311

15.94

307.65

1.8

1.2

g/l

0.2

2.26

581

288

(40760892) CBC W Ordered Manual Differential panel - Blood

1755

4375

3.87

307.65

9.1

3.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

994

514

17.17

307.65

1.9

1.4

—

(3022096) Basophils/100 leukocytes in Blood

3808

9539

7.35

307.65

12.7

4.6

0.6

0.7

2.77

3739

8793

(3000492) Spirometry study

1181

1906

5.54

307.65

2.9

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1778

4406

3.92

307.65

4.5

2.1

mg/mmol

11.9

6.3

3.62

1152

2268

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4397

19271

4.43

307.65

14.9

6.9

u/l

78.3

81.9

5.02

4303

17904

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1221

668

17.02

307.65

3.1

2.4

—

(3009508) Creatinine [Moles/volume] in Urine

1770

4492

3.81

307.65

3.6

1.8

mmol/l

7.2

8.1

13.08

1483

3785

(3026782) Osmolality of Urine

1626

4268

3.57

307.65

3.9

2.3

mosm/kgh2o

530.9

567.0

9.09

1466

3578

(3006504) Eosinophils/100 leukocytes in Blood

3837

9871

7.20

307.65

12.9

4.6

2.8

2.9

0.56

3761

9087

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

511

221

18.67

307.65

2.7

1.4

—

(3018418) pH of Serum or Plasma

2459

6266

4.42

307.65

5.7

3.5

7.4

0.37

581

1123

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1561

1957

7.81

307.65

2.6

1.6

—

(4010399)

1096

1407

6.92

307.65

2.0

1.4

—

(44790048)

418

188

17.63

307.65

2.7

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

546

362

12.22

307.65

12.7

3.8

iu/ml

1577.0

531.7

0.43

127

(3037467) Urinalysis macro (dipstick) panel - Urine

3792

15793

3.49

307.65

6.9

3.1

—

(3002582) Erythrocytes [#/volume] in Urine

2269

7021

3.35

307.65

5.0

2.7

e6/l

36.2

133.2

3.68

1851

5102

(3013826) Glucose [Moles/volume] in Serum or Plasma

3584

12702

4.11

307.65

8.8

3.8

mmol/l

6.8

6.3

44.77

3451

11784

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1712

1786

9.81

307.65

1.3

1.1

u/ml

27.3

2.0

5.82

503

657

(3024561) Albumin [Mass/volume] in Serum or Plasma

2928

9737

3.60

307.65

6.6

4.7

g/l

33.6

35.1

32.19

2736

9015

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1976

2931

7.20

307.65

2.8

1.6

—

(3021589) Normoblasts [#/volume] in Blood

3038

10657

3.46

307.65

19.2

7.4

e9/l

0.0

0.08

2618

8457

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

665

229

24.19

307.65

2.1

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1019

1872

4.69

307.65

12.2

7.9

g/l

123.9

120.4

4.31

988

1800

(3042936) Bacteria identified in Isolate by Culture

1481

2457

5.71

307.65

2.6

1.7

—

(3000850) Epithelial cells [#/volume] in Urine

1707

4445

3.65

307.65

3.9

2.3

e6/l

4.5

5.3

0.94

1556

3796

(3013650) Neutrophils [#/volume] in Blood by Automated count

4155

13025

6.57

307.65

16.1

9.1

e9/l

4.7

4.0

52.79

3866

11027

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

516

294

14.16

307.65

1.2

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1481

3345

4.10

307.65

1.9

1.4

g/l

2.8

2.4

5.25

1078

1894

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1225

2518

4.32

307.65

2.9

2.0

20.9

23.8

8.29

1046

2172

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2572

5936

5.12

307.65

4.2

2.5

ng/l

1645.9

1293.4

2.94

2330

5123

(3004616) Nuclear Ab [Presence] in Serum

302

106

22.14

307.65

1.4

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1196

2543

4.15

307.65

1.6

—

(3012516) Albumin [Mass/volume] in Urine

1717

4159

3.97

307.65

3.7

1.8

mg/l

730.3

454.5

0.95

1149

2140

(3009343) pH of Capillary blood

797

883

7.60

307.65

6.1

3.9

7.4

0.57

139

112

(3030467) Casts [#/volume] in Urine by Automated count

2104

6343

3.34

307.65

4.8

2.6

e6/l

0.4

0.6

3.08

1672

4474

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

706

121

49.15

307.65

2.3

1.3

—

(3023419) Bacteria identified in Sputum by Culture

593

211

23.07

307.65

2.8

2.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

783

849

7.75

307.65

5.9

3.8

mmol/l

2.2

2.0

0.57

621

612

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

554

198

22.80

307.65

1.3

1.1

u/ml

19.0

2.1

1.85

(3002179) Metamyelocytes/100 leukocytes in Blood

1023

1405

6.36

307.65

5.8

3.5

0.5

0.6

0.55

316

368

(3031040) Bacteria [#/volume] in Urine by Automated count

3623

15421

3.15

307.65

6.4

3.3

e6/l

1048.3

705.1

0.27

246

(3000494) Fungus identified in Specimen by Culture

1371

2379

5.32

307.65

2.4

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

751

635

9.93

307.65

1.9

2.1

u/l

38.4

39.7

0.66

685

567

(44790049)

418

188

17.63

307.65

2.7

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

560

238

19.18

307.65

2.4

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

619

398

12.78

307.65

2.4

2.0

g/l

128.3

130.3

0.53

240

299

(36304419) Bacteria [Presence] in Urine

2071

6133

3.39

307.65

4.7

2.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

803

893

7.58

307.65

6.1

3.9

kpa

5.1

0.95

759

822

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

608

318

15.70

307.65

1.8

1.2

g/l

1.2

0.00

587

295

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1564

1953

7.85

307.65

2.7

1.6

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3629

12354

4.44

307.65

10.3

7.3

umol/l

11.1

12.9

9.88

3524

11747

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2430

7661

3.40

307.65

5.2

2.6

ng/l

109.9

72.5

0.22

1916

5075

(3005719) IgG [Mass/volume] in Serum or Plasma

1256

1119

10.42

307.65

4.2

2.6

g/l

10.2

10.9

2.75

1199

1010

(3021440) Promyelocytes/100 leukocytes in Blood

1015

1462

6.04

307.65

6.1

3.5

0.1

0.35

367

449

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

596

248

19.73

307.65

1.4

1.1

u/ml

8.1

2.2

1.01

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

564

249

18.47

307.65

1.8

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

945

1697

4.74

307.65

4.1

2.4

ng/l

218.4

231.3

0.29

883

1565

(3019069) Monocytes/100 leukocytes in Blood

3842

9931

7.18

307.65

13.3

4.8

8.9

8.8

0.39

3768

9186

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3473

10970

4.63

307.65

10.9

5.4

mmol/l

1.2

1.74

2923

9150

(3019198) Lymphocytes [#/volume] in Blood

4083

10575

8.22

307.65

12.3

4.5

e9/l

1.9

0.43

3780

8920

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1707

3750

4.41

307.65

2.5

1.5

mg/l

1.6

1.7

0.36

1406

2890

(3005322) IgE [Units/volume] in Serum or Plasma

887

989

7.68

307.65

1.6

1.2

u/ml

253.2

314.1

0.58

824

913

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

391

275

11.19

305.26

5.4

2.1

u/ml

723.1

1198.3

0.31

(3022313) Gas panel - Capillary blood

546

615

7.15

303.01

6.5

4.3

—

(3009261) Glucose [Presence] in Urine by Test strip

2812

10836

2.87

300.82

4.9

2.6

estimate

0.0

0.00

755

1874

(3021601) Nitrite [Presence] in Urine by Test strip

2787

10701

2.87

299.89

6.6

3.6

estimate

0.0

0.80

771

1860

(3024980) IgG subclass 4 [Mass/volume] in Serum

366

243

11.81

295.59

1.7

1.4

g/l

1.0

0.9

0.08

266

174

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

281

108

20.13

294.36

1.3

1.1

u/ml

—

(40758558) Short blood count panel - Blood

1902

5967

3.06

293.44

11.3

7.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

742

1193

5.14

291.15

2.0

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

317

166

14.86

290.51

2.1

1.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

322

175

14.33

289.73

2.1

1.8

—

(4062490)

291

127

17.76

289.65

1.5

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

291

128

17.62

288.68

1.5

1.3

g/l

0.5

0.4

0.28

202

(3027135) IgG subclass 1 [Mass/volume] in Serum

292

130

17.41

288.18

1.5

1.2

g/l

7.6

7.1

0.80

202

(3028192) IgG subclass 2 [Mass/volume] in Serum

291

129

17.48

287.72

1.5

1.2

g/l

3.0

3.3

0.79

202

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

277

109

19.65

287.50

2.1

1.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

406

336

9.53

285.09

4.7

3.9

59.0

57.3

0.95

406

336

(1616796) Gas panel - Central venous blood

400

336

9.37

277.91

5.5

3.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

259

21.24

277.03

2.1

1.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2228

7835

2.84

276.93

4.4

4.2

mmol/l

2.3

2.4

5.53

2009

6872

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

260

20.88

276.35

2.1

1.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1273

3244

3.46

273.19

1.9

1.6

nmol/l

1151.4

1137.6

0.18

959

2327

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

291

145

15.54

272.93

2.2

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2324

8429

2.79

271.29

3.4

2.2

ug/l

197.3

155.9

5.22

2141

7789

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1493

4228

3.20

270.70

5.2

3.0

ng/l

465.7

925.7

3.67

1310

3415

(3027945) Reticulocytes/100 erythrocytes in Blood

1030

2284

3.86

270.52

3.5

2.5

1.9

1.7

9.70

921

2047

(3002032) Base excess in Venous blood by calculation

855

1647

4.34

270.42

5.1

2.9

mmol/l

2.2

1.9

1.16

710

1337

(3021447) Carbon dioxide [Partial pressure] in Venous blood

852

1654

4.31

266.66

5.1

2.9

kpa

5.9

5.8

1.89

816

1606

(3012544) pH of Venous blood

874

1733

4.23

266.25

5.0

3.0

7.4

—

(3015736) pH of Urine

2202

7824

2.79

266.14

4.1

2.5

—

5.8

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

889

1787

4.18

266.08

1.6

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2237

8039

2.77

264.17

2.2

1.6

pmol/l

92.0

94.3

1.31

1200

3939

(3014576) Chloride [Moles/volume] in Serum or Plasma

1128

2708

3.60

263.98

12.4

7.0

mmol/l

103.8

104.7

6.09

1096

2669

(3021788) Differential panel - Synovial fluid

215

31.64

260.57

1.7

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

176

111.51

259.51

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

176

111.51

259.51

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

176

111.51

259.51

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

176

111.51

259.51

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

406

391

8.17

254.97

4.7

3.1

mmol/l

25.2

24.9

0.44

372

334

(3026008) Bacteria identified in Urine by Culture

1830

6014

2.86

253.61

3.7

2.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

725

1303

4.57

248.74

12.7

6.9

mmol/l

25.1

24.8

1.14

717

1294

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

198

35.13

246.36

1.3

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1098

2715

3.47

244.34

4.6

5.0

u/l

264.2

259.2

0.30

1042

2597

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1892

6448

2.77

243.20

3.0

2.5

u/l

57.2

64.0

3.91

1766

5906

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

255

124

15.83

241.66

1.5

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

376

352

8.37

241.07

3.4

2.1

15.8

16.2

0.66

202

165

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

642

1077

4.84

238.44

2.0

1.5

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

852

1795

3.95

238.19

11.6

7.1

mmol/l

1.4

1.3

4.09

807

1724

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

591

933

5.11

234.86

1.7

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

668

1180

4.61

233.39

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

803

1660

4.00

229.87

3.4

2.7

e9/l

74.1

66.2

4.89

567

1239

(3000991) Gas panel - Venous blood

819

1728

3.93

227.98

13.1

7.8

—

(3000475) Leukocytes [#/volume] in Synovial fluid

221

19.00

226.93

1.8

1.2

e6/l

14387.3

25993.3

0.40

168

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

922

2161

3.57

220.71

1.6

1.5

—

(3033658) Prothrombin time (PT) actual/Normal

1772

6102

2.68

219.30

6.4

3.5

85.9

89.3

5.91

1738

5982

(3027315) Oxygen [Partial pressure] in Blood

371

385

7.54

219.16

7.3

3.2

kpa

8.3

8.7

2.88

364

376

(3021901) Oxygen saturation in Capillary blood

328

293

8.70

217.46

4.5

2.6

—

(3013290) Carbon dioxide [Partial pressure] in Blood

366

383

7.47

214.68

7.3

3.2

kpa

5.0

4.9

1.04

359

374

(3012501) Base excess in Blood by calculation

366

383

7.47

214.68

7.3

3.2

mmol/l

2.8

2.7

0.21

284

254

(3010421) pH of Blood

394

450

6.87

214.64

7.1

3.1

7.4

0.00

359

374

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

149

80.50

212.89

3.1

1.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

419

518

6.36

212.56

7.3

4.5

mmol/l

25.1

24.8

0.70

396

474

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

344

340

7.88

211.18

1.4

1.3

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

158

49.87

211.17

3.6

1.4

ug/l

42.9

48.6

0.40

158

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4666

25851

3.21

210.11

34.2

9.5

mg/l

24.4

29.1

19.87

4368

18439

(3007853) Bacteria identified in Skin by Aerobe culture

869

2020

3.57

209.94

2.2

1.5

—

(3028626) Oxygen [Partial pressure] in Capillary blood

366

406

7.04

204.32

5.8

3.9

kpa

7.8

8.2

3.04

350

375

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

341

348

7.62

203.99

1.3

u/ml

33.2

14.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1441

4605

2.77

203.78

1.8

1.4

nmol/l

19.0

20.4

2.71

1284

3823

(3023420) DNA double strand Ab [Units/volume] in Serum

195

18.57

198.61

1.9

1.1

iu/ml

21.3

—

(3011412) CD3 cells [#/volume] in Blood

244

161

11.63

197.04

2.3

2.2

e9/l

1.0

1.2

1.15

167

105

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

409

537

5.98

195.74

1.7

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

209

108

14.77

192.19

4.1

3.7

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

314

313

7.77

191.26

1.4

1.3

u/ml

132.2

111.7

0.49

(3024354) Oxygen [Partial pressure] in Venous blood

657

1340

3.96

189.90

3.9

2.5

kpa

4.6

0.14

627

1292

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

177

21.00

189.16

1.2

1.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

177

21.00

189.16

1.2

1.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

177

21.00

189.16

1.2

1.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

177

21.00

189.16

1.2

1.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

177

21.00

189.16

1.2

1.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

177

21.00

189.16

1.2

1.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1234

3771

2.82

188.00

1.8

1.5

pmol/l

43656801.4

27066891.5

0.31

1001

3085

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

236

161

11.23

186.79

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

236

161

11.23

186.79

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

236

161

11.23

186.79

1.6

1.7

—

(3014007) Fractional oxyhemoglobin in Arterial blood

628

1262

4.01

184.96

14.9

9.4

92.4

94.3

8.91

622

1257

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

377

489

6.02

182.35

3.5

2.1

ug/l

396.7

442.2

0.16

358

469

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

164

23.45

182.20

2.2

1.4

u/ml

71150.2

3508.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1227

3846

2.74

177.11

3.9

2.5

e6/l

0.9

1.4

1.92

704

2009

(3029937) Albumin [Presence] in Urine by Test strip

1566

5556

2.50

176.16

5.4

2.8

estimate

0.0

1.34

720

1736

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

503

889

4.48

174.05

5.1

3.2

mmol/l

24.4

24.2

0.33

450

825

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1206

3781

2.73

173.65

4.2

2.5

e6/l

1.6

2.1

1.42

681

1960

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

593

1197

3.97

173.22

16.0

9.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

392

558

5.49

172.70

2.4

2.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

392

558

5.49

172.70

2.4

2.1

g/l

7.8

7.1

6.51

311

429

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

391

557

5.49

172.12

2.4

2.1

g/l

3.9

3.8

0.14

302

399

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

429

667

5.05

172.05

4.0

2.7

u/ml

0.3

0.24

267

353

(3011397) Hemoglobin [Presence] in Urine by Test strip

1384

4683

2.57

171.09

4.3

2.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

321

375

6.63

170.90

1.5

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

321

375

6.63

170.90

1.5

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

140

32.02

170.44

1.6

1.1

58.1

63.9

0.27

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

242

199

9.32

169.76

1.9

1.3

—

(3036489) Thrombin time

418

643

5.10

169.57

3.3

1.8

21.7

22.1

0.38

381

578

(3028271) Lactate [Moles/volume] in Capillary blood

269

260

7.96

167.65

2.4

1.5

mmol/l

1.7

0.08

263

253

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

415

645

5.04

166.40

3.3

2.0

g/l

3.8

3.6

2.36

405

619

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

733

1761

3.38

166.40

5.1

3.2

mmol/l

1.2

5.15

675

1483

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

822

2127

3.17

165.78

4.9

2.7

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

375

533

5.49

165.36

2.4

2.1

g/l

3.3

3.1

3.01

306

418

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

372

526

5.51

164.90

2.4

2.1

g/l

10.6

0.05

319

437

(3044941) Cell count panel - Synovial fluid

153

21.43

164.84

1.8

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

240

204

9.01

164.48

1.3

1.2

u/ml

4.5

1.9

0.56

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2005

8190

2.26

161.88

5.2

2.7

—

(3020891) Body temperature

414

659

4.92

161.56

6.0

3.9

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

191

116

12.52

161.46

1.4

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

344

463

5.77

160.20

2.6

3.9

mg/l

60.6

51.7

0.56

243

388

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

466

829

4.43

159.63

2.0

1.7

g/l

1.6

1.5

1.58

395

695

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

837

2241

3.06

159.07

2.3

2.2

g/l

0.2

0.31

785

2119

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

342

461

5.76

159.01

2.6

3.9

mg/l

44.7

39.3

0.43

240

386

(3042733) HLA Ab [Presence] in Serum

130

31.59

157.75

4.2

3.7

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

227

191

9.08

156.64

1.3

1.2

u/ml

3.4

4.7

0.58

134

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

332

445

5.78

155.18

2.6

3.9

ratio

4.3

4.6

0.03

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

195

132

11.24

154.89

2.2

1.7

15.4

14.0

0.39

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3472

17861

2.18

154.56

4.1

3.1

pmol/l

14.9

14.8

3.97

3147

15839

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

323

424

5.90

154.08

2.4

2.1

g/l

0.1

0.09

301

384

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

190

127

11.37

152.04

2.4

1.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

344

488

5.47

151.80

2.4

g/l

0.7

1.6

1.84

309

411

(3001964) Herpes simplex virus Ag [Presence] in Specimen

139

21.84

150.86

2.9

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

391

634

4.81

149.22

3.4

1.9

90.2

85.4

3.17

375

594

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

305

392

6.01

148.43

2.5

2.1

g/l

0.0

0.00

283

354

(3018405) Lactate [Moles/volume] in Arterial blood

362

554

5.08

147.33

4.8

3.6

mmol/l

1.4

0.10

357

549

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2365

10623

2.12

147.26

5.1

3.4

—

(4306422)

227

208

8.34

147.20

1.3

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1232

4203

2.49

147.04

2.9

3.7

mmol/l

2.5

6.25

1095

3698

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

536

1129

3.76

146.92

4.3

3.0

ng/l

103.8

82.8

3.28

466

957

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

321

441

5.63

146.28

2.4

2.1

g/l

36.1

37.9

3.71

292

377

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

301

388

5.98

146.04

2.5

2.2

g/l

0.0

0.00

283

354

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

223

202

8.43

145.84

1.2

1.1

118.9

111.3

1.96

214

174

(40768797) Stomach Pathology biopsy report

921

2731

2.78

145.06

1.3

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

430

782

4.31

143.00

6.4

4.8

1.8

1.7

1.50

405

728

(3044889) 12 lead EKG panel

3571

18893

2.12

142.10

5.7

3.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

122

26.99

141.79

2.2

1.0

u/l

6.0

5.1

0.77

109

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

355

569

4.84

137.09

3.6

1.9

209.3

197.7

1.26

339

539

(3037756) Immunofixation for Serum or Plasma

265

320

6.35

136.62

1.5

1.9

—

(21494815) CD4 cells/100 lymphocytes in Specimen

192

162

9.00

132.10

2.4

2.0

32.9

34.6

0.13

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

301

431

5.38

131.31

1.4

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1507

5874

2.23

131.03

4.8

2.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1109

3782

2.45

130.84

1.3

1.2

u/ml

1.1

3.0

5.87

269

931

(40757373) Influenza virus identified in Isolate

112

27.13

130.39

2.9

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

213

7.62

129.00

1.2

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

117

22.54

128.46

41.2

28.2

ug/l

8.0

7.5

1.09

106

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

140

14.46

127.94

1.5

1.1

—

(4268621)

168

123

10.34

127.06

2.3

2.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

485

1057

3.61

126.09

4.9

2.9

g/l

125.5

128.6

1.78

466

1035

(40760888) Immunoglobulin light chains.free panel - Serum

261

340

5.88

125.17

2.5

4.0

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

181

153

8.97

124.34

1.2

1.1

95.9

95.0

0.13

176

138

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

167

126

10.03

123.88

1.6

1.2

u/ml

2.1

2.0

0.02

110

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

247

308

6.13

123.50

1.2

u/ml

341.1

272.5

1.51

164

201

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4070

23200

2.13

123.32

5.1

3.5

mu/l

2.1

2.4

1.23

3726

20530

(3022217) INR in Platelet poor plasma by Coagulation assay

854

2636

2.64

123.10

28.4

21.7

inr

1.5

1.4

0.11

337

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

256

333

5.89

122.93

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

158

111

10.76

122.59

2.2

2.4

e6/l

470.9

535.7

0.56

130

(3007930) Methemoglobin/Hemoglobin.total in Blood

398

769

4.03

122.09

6.9

4.8

0.9

0.34

374

717

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

610

1572

3.09

122.01

2.6

2.0

ug/l

11.8

11.7

0.02

535

1399

(40761536) Microorganisms panel - Urine sediment

681

1890

2.89

119.69

5.1

2.9

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3045

15754

1.95

119.31

4.5

2.5

u/l

67.5

48.2

11.11

2839

14417

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

109

22.10

118.90

1.7

1.2

37.1

28.0

0.66

(3047181) Lactate [Moles/volume] in Blood

335

577

4.49

118.70

8.8

5.9

mmol/l

1.4

1.3

0.63

308

506

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

164

129

9.62

118.35

1.2

1.1

titre

121.0

155.9

0.17

(3027273) Bicarbonate [Moles/volume] in Venous blood

396

786

3.92

117.11

4.7

2.6

mmol/l

25.7

25.3

0.96

370

765

(3024471) HLA-A [Type]

121

16.24

116.86

1.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

171

147

8.81

116.04

1.1

—

(3024932) HLA-DR beta [Type]

119

16.56

115.92

1.0

1.2

—

(3028433) Virus identified in Specimen by Culture

122

15.54

115.50

1.2

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

844

2687

2.55

113.70

3.1

2.7

umol/l

9.7

11.4

0.87

737

2407

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

181

176

7.79

112.00

1.4

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

293

474

4.75

111.66

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

166

146

8.60

110.79

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

145

105

10.41

110.37

2.3

2.5

e9/l

0.2

0.60

128

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4181

24525

2.07

108.74

6.9

3.3

mmol/mol

41.4

37.0

103.15

3882

21933

(3017569) Oxygen content in Arterial blood

123

13.21

107.49

2.2

1.8

—

(3043409) Potassium [Moles/volume] in Arterial blood

287

472

4.67

107.27

5.4

3.8

mmol/l

4.0

3.9

2.64

262

447

(3002385) Erythrocyte distribution width [Ratio]

3980

23001

2.00

106.64

37.6

12.5

14.3

13.7

96.48

3948

22262

(3044640) Blood type and Crossmatch panel - Blood

1670

7233

2.01

106.54

3.3

2.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2723

14048

1.85

101.01

3.0

2.4

—

(3052851) Hemolysis interference index of Serum or Plasma

310

575

4.15

99.97

4.4

3.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

110

14.23

99.91

2.3

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

145

122

8.96

99.86

1.7

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

145

122

8.96

99.86

1.7

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

145

122

8.96

99.86

1.7

1.9

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

174

187

7.04

99.21

2.2

2.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

144

122

8.90

98.69

1.7

1.9

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

359

751

3.70

98.44

4.0

2.4

0.7

0.6

0.79

351

723

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

128

10.35

97.20

1.7

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

128

10.35

97.20

1.7

2.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

128

10.24

96.54

1.7

2.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

169

183

6.98

95.74

1.1

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

111

12.61

94.75

2.2

1.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

4664

29019

2.23

94.48

35.0

11.2

mmol/l

139.1

139.9

71.78

4611

27834

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

368

812

3.50

93.33

2.7

1.8

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

4666

29143

2.20

91.28

35.3

11.3

mmol/l

4.0

23.52

4608

27894

(3013512) EKG study

1556

6896

1.92

90.13

5.1

3.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

222

340

4.97

89.83

4.1

3.6

1.5

2.0

1.00

198

260

(3018572) Chloride [Moles/volume] in Blood

253

434

4.45

89.82

8.8

6.7

mmol/l

103.9

105.3

3.95

233

385

(3039000) Anion gap in Blood

253

434

4.45

89.82

8.8

6.7

mmol/l

11.6

10.9

2.18

233

385

(4015189)

13.72

88.38

2.3

1.8

—

(3009871) Measles virus Ab [Titer] in Serum

13.44

85.70

1.3

1.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

125

106

8.86

85.59

2.7

2.0

ug/min

124.6

72.5

0.60

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

26.28

85.38

1.4

1.8

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

130

119

8.21

84.19

2.4

2.7

e6/l

663.7

561.0

0.47

(3019977) pH of Arterial blood

119

9.02

82.58

2.6

1.8

7.4

0.34

(3025941) Bacteria identified in Stool by Culture

377

918

3.17

81.86

1.4

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1284

5499

1.94

80.95

3.1

2.2

—

(3034426) Prothrombin time (PT)

15.89

79.53

1.1

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

118

105

8.43

78.03

1.1

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

233

421

4.21

77.51

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

248

471

4.01

77.37

1.4

ug/g

286.3

267.5

0.27

151

291

(3008536) Aspergillus sp Ab [Presence] in Serum

15.30

77.24

1.7

2.6

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

180

261

5.21

77.23

1.1

g/l

1.6

1.5

0.99

159

243

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

524

1594

2.57

75.88

3.7

2.6

ml/min/173m2

57.8

65.4

4.10

247

556

(3023183) Ammonium ion [Moles/volume] in Plasma

207

346

4.54

75.73

2.8

2.2

umol/l

33.4

38.3

1.18

184

305

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

243

468

3.95

74.41

1.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

250

492

3.87

74.36

1.4

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

319

743

3.29

74.24

2.3

1.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

634

2131

2.35

74.13

2.7

2.3

u/l

35.4

39.5

1.00

573

1865

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

243

472

3.92

73.56

1.4

1.3

—

(3011436) Histone Ab [Units/volume] in Serum

23.40

73.44

1.0

u/ml

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

117

112

7.84

73.22

2.3

2.8

40.4

35.0

1.16

(3019150) Specific gravity of Urine by Refractometry

1047

4315

1.97

72.86

5.3

2.8

kg/l

1.0

0.03

186

654

(40761511) CBC panel - Blood by Automated count

4558

28877

1.96

72.47

26.6

9.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

9.83

70.77

1.1

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

239

481

3.78

68.92

1.2

1.3

titre

1203.6

502.6

1.62

(3048689) Calprotectin [Mass/mass] in Stool

614

2101

2.30

68.67

2.5

2.4

ug/g

187.5

146.9

1.44

508

1652

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

150

213

5.30

65.78

8.5

6.1

mg/l

11.9

11.4

0.64

137

200

(3007566) Smooth muscle Ab [Titer] in Serum

237

492

3.66

65.41

1.2

1.3

titre

107.1

313.9

0.84

(3010144) Erythrocytes [#/volume] in Synovial fluid

13.60

64.98

1.6

1.1

e6/l

118343.6

128899.5

0.04

(3017732) Neutrophils [#/volume] in Blood

443

1338

2.56

64.77

3.3

2.7

e9/l

4.6

3.9

6.37

354

1019

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

230

471

3.71

64.71

1.3

1.2

—

(3044927) Protein electrophoresis panel - Urine

105

106

7.41

63.01

1.2

1.1

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4674

30320

1.91

60.66

35.8

11.8

umol/l

86.4

77.7

31.66

4674

30291

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

235

518

3.44

59.40

3.6

2.8

mg/l

1.8

1.3

10.54

219

473

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

8.41

58.96

1.2

ratio

1.1

0.11

(3003327) Ova and parasites identified in Stool by Light microscopy

247

574

3.27

57.56

1.9

1.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4668

30405

1.88

57.23

21.0

7.6

u/l

25.1

25.5

0.85

4607

28884

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

23.67

56.94

1.2

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

158

269

4.42

56.52

1.2

1.3

—

(40768804) Tissue Pathology biopsy report

2133

11471

1.60

56.36

2.4

2.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

149

249

4.50

54.50

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

9.71

53.50

1.1

iu/ml

73.1

29.1

0.32

(3044290) Cell count panel - Cerebral spinal fluid

110

141

5.84

53.47

1.2

1.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

96.82

53.28

1.5

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

599

2242

2.09

53.08

1.7

1.5

1.6

1.4

8.53

504

1964

(3027456) Digoxin [Moles/volume] in Serum or Plasma

176

343

3.87

52.99

2.9

nmol/l

0.9

0.8

0.98

131

257

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

160

290

4.15

52.97

2.9

2.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

9.54

52.88

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

137

221

4.65

52.24

4.7

3.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

121

175

5.18

52.06

1.2

1.3

mg/l

772.2

462.0

0.72

109

161

(3040151) Glucose [Moles/volume] in Capillary blood

120

174

5.17

51.49

9.6

2.9

mmol/l

7.4

6.2

2.90

103

148

(3042111) Morphology [Interpretation] in Bone marrow Narrative

191

404

3.57

51.29

1.8

1.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

8.75

50.53

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4192

26775

1.65

50.10

28.7

10.0

ml/min/173m2

75.0

78.8

26.12

3797

20893

(3026389) Candida sp identified in Specimen by Organism specific culture

123

190

4.85

49.27

1.6

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

142

248

4.30

49.25

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

7.55

48.28

1.7

—

(40761535) Cells panel - Urine sediment

425

1438

2.27

48.20

4.7

2.4

—

(3024928) Oxygen saturation in Venous blood

187

408

3.46

47.98

4.2

3.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

10.80

47.85

2.3

3.6

—

(3004775) Volume in Urine collected for unspecified duration

10.19

47.66

2.3

1.7

613.4

674.2

0.39

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

108

154

5.25

47.18

1.1

1.3

mmol/l

3.7

3.5

1.19

147

(4035726)

733

3088

1.86

45.94

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

303

898

2.57

45.75

2.8

3.0

pmol/l

4.2

4.5

2.66

261

789

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

10.86

44.88

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

113

176

4.80

44.87

1.3

1.1

—

(40768446) Kidney Pathology biopsy report

12.30

44.81

1.4

1.8

—

(36660697) Celiac disease serology panel - Serum

408

1401

2.24

44.61

1.2

1.1

—

(3004451) EKG impression Narrative

7.66

44.54

1.4

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

346

1115

2.37

43.76

2.6

2.3

—

(3029075) Extractable nuclear Ab panel - Serum

10.67

43.62

1.1

1.0

—

(3045716) Anion gap in Serum or Plasma

7.44

42.96

3.0

1.9

mmol/l

8.3

8.5

0.11

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

103

156

4.93

42.20

1.1

1.3

e6/l

35.9

10.2

0.71

113

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

103

156

4.93

42.20

1.2

1.4

e6/l

593.9

408.9

0.13

119

(4146454)

9.33

42.18

2.4

1.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

110

177

4.65

42.10

1.7

1.3

u/l

13.7

11.5

2.36

105

168

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

154

323

3.58

41.88

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

292

892

2.49

41.40

1.3

au/ml

43.5

47.8

0.10

(3045142) Bone marrow Pathology biopsy report

146

299

3.67

41.08

1.5

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

316

1006

2.39

41.02

2.4

2.3

au/ml

50.0

26.9

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4208

27343

1.57

40.70

5.3

3.5

mmol/l

6.0

5.6

64.88

3810

24558

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

160

352

3.42

40.56

1.6

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

10.36

40.55

1.0

1.1

—

(3016750) Collection duration of Urine

10.03

40.48

2.2

1.8

min

475.4

484.7

0.17

(40768443) Skin Pathology biopsy report

317

1018

2.37

40.36

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

129

246

3.93

40.02

1.4

1.2

u/l

473.2

591.7

0.34

120

238

(3036782) Glucose [Moles/volume] in Pleural fluid

136

273

3.73

39.36

1.5

1.3

mmol/l

6.6

5.4

3.69

123

250

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

7.68

39.11

1.2

1.5

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

7.55

38.62

1.0

1.1

98.3

88.6

2.13

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

157

4.71

38.54

2.6

2.4

—

(3012441) Differential panel - Pleural fluid

142

299

3.56

38.41

1.5

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

165

384

3.23

38.36

1.5

1.3

g/l

32.8

34.4

0.73

141

348

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

17.60

38.06

2.3

1.2

ug/min

10.8

10.3

—

(3037121) Protein [Mass/volume] in Urine

234

669

2.64

37.90

3.0

3.6

g/l

0.3

0.2

2.75

119

337

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

108

188

4.29

37.66

1.1

1.2

u/l

56.5

58.1

0.09

120

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

172

417

3.10

37.43

1.2

1.3

miu/ml

195.3

218.2

0.28

193

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

103

174

4.42

37.25

1.8

1.6

mg/l

4.5

3.2

1.50

166

(3009542) Hematocrit [Volume Fraction] of Blood

3957

25554

1.50

36.95

33.5

11.0

38.9

40.0

8.98

2567

18820

(3022145) Colonoscopy Study observation

640

2763

1.80

36.59

1.4

1.3

—

(3024263) Appearance of Synovial fluid

9.83

36.29

1.9

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

6.26

36.06

4.0

2.4

—

(3019225) pH of Specimen

539

2219

1.87

35.83

5.4

3.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

108

198

4.08

35.30

1.3

1.2

u/l

14.2

12.7

0.29

189

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

9.96

35.12

1.1

88.5

92.9

0.22

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

9.62

35.07

1.1

86.3

91.1

0.28

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

10.43

34.60

1.7

1.4

ug/l

8.4

10.9

1.12

(42529406) Shigella sp [Presence] in Stool by Culture

185

490

2.84

34.58

1.3

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

184

486

2.85

34.57

1.3

1.1

—

(3008898) HLA-B27 [Presence]

122

249

3.67

34.53

1.1

1.0

—

(3000060) B lymphocytes [#/volume] in Blood

8.60

34.51

2.3

1.5

e6/l

940.8

1391.1

0.13

(3016650) Hepatitis A virus Ab [Presence] in Serum

142

322

3.31

34.40

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

5.74

34.22

1.7

1.6

—

(3003181) Sodium [Moles/volume] in Urine

136

301

3.38

34.20

1.5

1.2

mmol/l

65.7

64.9

0.06

122

227

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

182

485

2.82

33.65

1.3

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1303

6883

1.52

33.26

1.8

1.5

mmol/l

1.4

1.2

12.12

1076

5742

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

13.70

33.10

1.2

1.7

—

(3051651) Icteric interference index of Serum or Plasma

141

4.60

33.07

6.2

3.7

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

5.50

32.82

1.7

1.6

—

(3017704) Immunofixation for Urine

6.46

32.32

1.3

1.8

—

(3007461) Platelets [#/volume] in Blood

4736

32177

1.61

30.65

45.1

14.1

e9/l

249.1

245.9

2.32

4665

30587

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

11.26

30.60

1.7

1.3

—

(3035941) MCH [Entitic mass]

4737

32209

1.61

30.19

44.8

14.0

30.4

1.48

4700

31353

(3024731) MCV [Entitic volume]

4737

32221

1.60

29.96

44.8

14.0

92.3

91.1

54.92

4700

31366

(3010813) Leukocytes [#/volume] in Blood

4737

32223

1.60

29.92

45.0

14.1

e9/l

7.8

6.5

126.00

4654

30497

(3026361) Erythrocytes [#/volume] in Blood

4737

32225

1.60

29.88

45.0

14.0

e12/l

4.4

4.5

71.94

4652

30513

(3045788) Cell count panel - Pleural fluid

123

279

3.30

29.82

1.6

1.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

4737

32239

1.60

29.61

45.3

14.1

g/l

131.7

137.0

95.31

4699

31388

(21494890) Protein electrophoresis panel - 24 hour Urine

149

4.25

29.45

1.6

2.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

139

343

3.03

29.42

1.6

1.4

e6/l

5109.9

3430.9

0.21

233

(40768806) Pleura Pathology biopsy report

132

317

3.12

29.23

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

110

236

3.48

29.02

5.7

3.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

13.93

28.85

1.7

1.2

ug/l

0.3

0.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1930

11241

1.41

28.71

4.7

5.2

ug/l

3.1

4.1

0.71

1685

10182

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

10.54

28.65

1.1

—

(4027681)

13.16

28.04

1.3

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

104

225

3.45

27.12

1.7

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

5.83

27.01

6.1

5.5

mg/l

61.4

74.4

0.55

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

105

230

3.41

26.88

1.7

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

104

227

3.42

26.77

1.7

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4009

26538

1.42

26.63

4.4

3.3

mmol/l

1.3

1.2

37.11

3558

23798

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

129

324

2.98

26.53

1.1

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

130

328

2.96

26.53

1.2

1.4

u/l

46.7

45.9

0.01

112

279

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

103

225

3.41

26.48

1.7

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

103

225

3.41

26.48

1.7

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

103

225

3.41

26.48

1.7

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

5.50

26.42

1.7

1.6

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

5.50

26.42

1.7

1.6

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

100

4.83

26.27

1.1

1.3

u/l

44.0

20.9

1.39

(3017354) Segmented neutrophils/100 leukocytes in Blood

101

219

3.44

26.26

4.6

3.9

54.5

57.4

0.52

137

(3028308) Erythrocytes [#/volume] in Pleural fluid

127

319

2.98

26.12

1.6

1.4

e6/l

126515.9

28641.6

1.59

180

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

104

4.72

25.97

1.1

1.3

u/l

93.2

91.9

0.03

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

641

3037

1.63

25.66

1.5

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

6.94

25.28

1.5

1.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

10.76

25.10

1.3

1.0

ng/l

94.8

162.9

0.31

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4263

28656

1.43

24.63

5.4

4.0

mmol/l

2.6

2.9

137.97

3836

25869

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

144

3.98

24.62

1.3

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

127

333

2.85

24.25

1.1

1.0

—

(21494755) Public health laboratory ask at order entry panel

153

2540

0.43

24.24

1.3

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

119

4.25

23.67

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

119

4.25

23.67

1.4

1.5

—

(3035880) pH of Pleural fluid

142

3.93

23.61

1.3

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

228

3.24

23.51

1.9

1.1

iu/l

4.7

2.3

1.48

(3019832) Treponema pallidum Ab [Presence] in Serum

280

1066

1.98

23.28

1.4

1.6

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

8.36

23.26

1.7

2.3

mg/l

5.8

9.7

2.95

(3046861) Legionella sp Ag [Presence] in Urine

27.95

23.12

1.1

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

16.13

23.10

1.6

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

178

2719

0.46

22.55

1.9

1.7

—

(3016018) Differential panel - Cerebral spinal fluid

4.86

22.45

1.2

1.5

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

7.85

22.21

1.1

1.0

mg/l

273.4

269.7

0.03

(3036603) Volume of Urine

122

4.08

22.21

1.4

1843.7

2226.8

0.83

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

4.77

21.60

1.6

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

7.40

21.23

1.2

1.0

mg/l

51.9

44.0

0.27

(3000012) Reticulocyte production index

114

4.10

21.06

2.1

1.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

147

449

2.45

20.92

1.1

u/ml

18.3

9.2

0.53

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4122

27793

1.37

20.78

4.9

3.6

mmol/l

1.4

1.5

44.77

3685

25145

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

4.68

20.77

1.6

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4151

28044

1.37

20.42

4.9

3.6

mmol/l

4.4

4.9

118.99

3733

25486

(3050794) Legionella sp Ab [Presence] in Serum

10.68

20.29

1.1

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

13.07

20.05

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

117

3.93

19.66

1.4

1.5

u/l

9.4

6.8

0.37

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

13.55

19.51

1.1

1.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

221

824

2.02

19.49

1.4

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

12.14

19.29

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

33.27

19.20

1.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

8.25

19.10

1.0

1.2

92.1

71.0

—

(3045424) Erythrocytes [Presence] in Urine

112

314

2.66

18.97

1.8

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

7.40

18.81

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

5.66

18.72

1.1

1.3

—

(21494434) Karyotype in Bone marrow

214

3.02

18.64

1.3

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

143

3.53

18.59

1.2

1.3

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

8.28

18.50

1.1

1.2

80.9

61.9

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

5.74

18.49

1.3

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

158

3.34

17.87

1.1

1.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

7.16

17.74

5.0

2.9

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

681

3538

1.48

17.70

3.1

5.0

ug/l

25.9

34.9

0.28

559

2933

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

5.35

17.70

1.1

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

190

695

2.05

17.67

1.3

1.2

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

6.58

17.63

1.1

1.3

60.7

90.2

—

(3022621) pH of Urine by Test strip

320

1392

1.74

17.52

4.2

2.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

5.41

17.45

1.4

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

231

2.87

17.41

2.7

1.8

mg/l

20.6

34.0

1.42

(3045414) Leukocytes [Presence] in Urine

221

859

1.93

17.35

2.3

1.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

5.99

17.23

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

7.15

17.13

1.3

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

14.03

17.12

1.7

1.4

mg/l

1.1

3.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

475

2306

1.57

16.93

1.7

1.5

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

8.01

16.77

1.0

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

4.30

16.75

1.1

1.0

u/ml

15.6

11.0

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

5.63

16.73

1.4

1.2

24.5

22.1

0.14

(3047189) Immunofixation for 24 hour Urine

4.18

16.55

1.7

1.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.27

16.55

3.5

1.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.27

16.55

3.5

1.7

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

6.07

16.43

5.9

1.4

umol/l

142.5

141.9

0.00

(3008295) Osmolality of Serum or Plasma

167

3.16

16.42

1.4

1.5

mosm/kgh2o

270.7

277.2

1.28

139

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

3.89

16.35

2.4

1.6

—

(3020491) Glucose [Moles/volume] in Blood

125

3.50

16.01

2.0

1.5

mmol/l

7.6

6.1

3.15

(3016038) Potassium [Moles/volume] in Urine

118

3.58

15.99

1.3

1.0

mmol/l

32.5

39.0

1.24

104

(3001893) Eosinophils/100 leukocytes in Pleural fluid

4.42

15.88

1.4

1.3

1.6

2.8

0.58

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

13.29

15.78

1.7

1.4

mg/l

3.9

2.4

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

13.29

15.78

1.7

1.4

mg/l

3.2

1.0

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

13.29

15.78

1.7

1.4

mg/l

1.5

5.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

113

1785

0.45

15.62

1.7

1.4

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

120

3.52

15.62

1.0

mg/l

290.7

295.0

0.16

110

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

4.05

15.57

1.4

1.3

61.9

58.8

0.18

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

8.50

15.48

1.0

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

214

2.81

15.40

1.1

—

(3014271) Vancomycin [Susceptibility]

5.03

15.36

2.8

2.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

4.66

15.30

2.7

2.2

—

(1002224) Polysomnography panel

149

529

2.10

15.04

1.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

4.12

14.94

1.3

1.7

—

(3006576) Bicarbonate [Moles/volume] in Blood

4.07

14.71

5.4

7.9

mmol/l

24.8

25.6

0.46

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

126

3.29

13.94

1.1

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

5.64

13.93

1.4

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.64

13.93

1.0

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

127

3.27

13.77

1.1

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

131

3.23

13.73

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

267

2.48

13.29

1.3

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

182

2.81

13.21

3.4

2.0

—

(3032057) Clostridioides difficile [Presence] in Stool

5.96

12.66

2.2

1.8

—

(40768795) Lymph node Pathology biopsy report

104

343

2.26

12.63

1.3

1.2

—

(44806071)

7.77

12.62

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

7.77

12.62

2.1

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

183

746

1.83

12.51

1.6

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

8.86

12.45

1.3

1.9

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

272

2.40

12.37

1.7

1.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

4.82

12.29

1.2

1.1

mmol/l

2.0

2.2

0.25

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

4.18

12.13

6.5

8.5

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

5.25

12.10

1.3

1.4

4.4

14.6

1.85

(3000034) Microalbumin [Mass/volume] in Urine

115

3.22

12.07

2.3

1.7

mg/l

63.8

26.9

0.68

(3049717) Cytology report of Urine Cyto stain

246

1110

1.66

11.83

2.9

3.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

262

1205

1.63

11.70

1.2

1.1

iu/ml

123.7

154.2

0.61

471

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

248

2.43

11.64

1.4

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.19

11.53

1.0

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

4.66

11.45

2.4

2.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

101

3.30

11.30

1.2

1.1

u/l

93.8

85.5

0.21

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

101

3.30

11.30

1.2

1.1

u/l

34.9

20.2

0.73

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

125

3.02

11.14

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

141

2.89

11.13

1.4

u/ml

13.0

19.8

—

(3035320) C reactive protein [Mass/volume] in Body fluid

137

2.92

11.13

3.0

2.2

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

6.20

11.03

1.5

1.1

70.1

71.0

0.04

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

7.84

10.79

1.1

1.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

101

3.22

10.70

1.3

1.2

—

(44813793)

109

3.12

10.64

1.1

—

(3011648) Oxygen content in Venous blood

175

2.63

10.54

6.2

2.8

10.8

11.2

0.25

175

(3018851) Theophylline [Moles/volume] in Serum or Plasma

6.99

10.46

1.7

1.6

umol/l

43.2

44.8

0.09

(3017446) Testosterone [Moles/volume] in Serum or Plasma

398

2064

1.45

10.32

2.7

1.9

nmol/l

12.7

13.2

0.54

343

1860

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

100

355

2.09

10.23

1.1

u/ml

1.4

1.8

0.13

147

(3035637) Corticotropin [Mass/volume] in Plasma

261

2.27

10.05

1.6

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

9.39

10.04

4.1

4.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1465

9191

1.24

10.02

4.2

4.3

21.7

21.1

0.66

656

4975

(3020191) Ethanol [Moles/volume] in Serum or Plasma

3.17

9.97

1.5

1.2

promille

1.1

1.6

1.10

(3009466) Valproate [Moles/volume] in Serum or Plasma

163

2.64

9.97

3.7

6.0

umol/l

340.5

396.9

1.78

139

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

118

2.95

9.90

1.1

iu/ml

7.1

10.4

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

6.97

9.86

1.2

1.0

iu/ml

6.8

5.7

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

6.10

9.84

1.4

1.0

u/l

383.8

33.6

0.60

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

231

2.34

9.83

1.5

1.2

nmol/l

12.8

0.7

0.49

221

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

229

2.33

9.60

1.6

1.2

nmol/l

0.2

0.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

211

2.39

9.57

1.6

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

286

2.18

9.56

1.1

u/ml

2.3

2.5

0.05

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

4.85

9.53

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

249

2.26

9.48

1.0

u/ml

3.3

4.3

0.24

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

5.47

9.36

1.2

1.1

mg/l

300.5

0.6

0.47

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

6.95

9.25

1.3

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

5.27

9.04

1.5

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

5.27

9.04

1.5

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

5.27

9.04

1.5

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

236

2.26

8.99

1.0

u/ml

1.6

3.0

0.87

(3003888) Timothy IgE Ab [Units/volume] in Serum

319

2.07

8.93

1.1

u/ml

3.7

5.0

0.33

160

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

8.72

8.86

1.2

1.3

ml/s/173m2

0.8

1.2

—

(44806420)

6.56

8.83

2.1

1.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

4.47

8.71

1.4

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.31

8.66

1.2

ug/l

160.9

312.2

0.32

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

13.84

8.56

12.5

8.6

mmol/l

5.6

4.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

195

2.36

8.52

1.5

1.2

nmol/l

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

3.26

8.50

1.0

1.1

—

(3048879) Bone marrow aspiration report

3.84

8.48

2.3

2.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

7.38

8.48

1.6

2.0

—

(4034850)

161

713

1.68

8.41

12.6

7.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.69

8.37

6.4

7.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

114

2.79

8.29

1.9

1.7

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

100

385

1.93

8.27

1.4

u/l

11.4

11.8

0.08

320

(3006653) Thiamine [Moles/volume] in Blood

4.56

8.15

1.0

1.6

nmol/l

136.8

132.0

0.11

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

4.76

8.14

1.2

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

3.69

8.08

1.4

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

5.90

8.05

1.0

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

15.98

7.87

1.4

1.0

—

(3006270) Folate [Moles/volume] in Blood

144

2.52

7.79

1.1

nmol/l

315.9

361.3

0.68

128

(3003694) ABO and Rh group [Type] in Blood

1212

7624

1.22

7.78

1.5

1.3

—

(3003338) MCHC [Mass/volume]

3472

23948

1.18

7.76

40.1

12.6

g/l

329.4

332.8

80.90

3451

23733

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

8.05

7.73

1.3

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

3.77

7.70

8.5

22.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

219

2.20

7.67

1.2

1.4

pmol/l

281.7

264.6

0.12

165

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.45

7.62

1.0

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

6.45

7.62

1.0

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

4.47

7.60

1.1

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

3.95

7.53

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

6.85

7.42

1.0

1.1

—

(3011985) Renin [Units/volume] in Plasma

233

2.13

7.34

1.2

1.5

mu/l

52.6

55.6

0.06

207

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.86

7.32

1.0

1.2

miu/ml

1808.3

1498.3

0.44

(3008401) Mugwort IgE Ab [Units/volume] in Serum

306

1.96

7.13

1.1

u/ml

0.5

2.3

1.65

141

(3013466) aPTT in Blood by Coagulation assay

8.11

7.11

1.0

34.5

35.5

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

8.11

7.11

1.8

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

4.22

7.11

1.3

1.0

mmol/l

0.5

1.0

0.48

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.62

7.01

1.4

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

6.39

7.01

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

5.74

6.87

1.1

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

6.81

1.1

mmol/l

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.27

6.79

1.1

—

(3001729) Color of Synovial fluid

16.22

6.76

2.0

1.6

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.42

6.75

1.3

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

12.64

6.72

1.4

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

200

2.15

6.53

1.0

u/ml

0.2

1.8

0.78

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

13.52

6.36

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

190

940

1.51

6.34

1.0

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

119

2.49

6.27

3.4

2.2

u/l

237.6

204.2

1.32

119

(3020393) Adenovirus Ag [Presence] in Stool

5.16

6.21

1.2

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

6.76

6.20

2.0

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

480

2790

1.29

6.11

9.3

5.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

241

2.00

6.09

1.1

1.0

—

(3014891) Appearance of Pleural fluid

4.02

6.07

1.9

1.5

—

(4024509)

173

2.18

6.00

1.7

1.4

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

14.75

6.00

1.0

2.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

5.33

5.95

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.91

5.85

1.1

1.6

—

(3044009) aPTT.lupus sensitive (LA screen)

6.24

5.80

1.4

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

3.69

5.74

1.4

1.3

pmol/l

320.3

368.1

0.13

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.69

5.74

1.4

1.2

iu/ml

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.79

5.64

1.2

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

5.05

5.64

1.2

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

3.14

5.52

1.3

g/l

0.4

0.3

2.15

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.72

5.28

1.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

4.30

5.12

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

405

1.68

5.08

1.4

1.8

mu/l

324.9

400.4

0.35

375

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

128

2.25

5.02

1.7

1.6

u/field

1.5

2.9

0.74

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

9.21

4.98

1.0

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.69

4.85

1.3

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

5.67

4.84

1.0

—

(3002256) Pathology report gross observation

646

3996

1.22

4.78

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

131

640

1.52

4.74

3.0

4.0

u/ml

98.5

1339.6

1.42

122

584

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

364

1.69

4.68

1.9

1.8

pmol/l

197.4

217.4

1.09

343

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

3.97

4.67

3.6

2.8

mg/l

0.7

0.9

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1060

0.63

4.66

1.6

—

(3000330) Specific gravity of Urine by Test strip

207

1111

1.39

4.59

4.6

2.8

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

119

2.23

4.58

1.1

2.0

umol/l

5.9

9.8

1.02

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

11.79

4.51

2.1

3.4

—

(40765096) Chromosome analysis panel by Banding

2.49

4.51

1.1

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.52

4.46

3.0

2.2

—

(3014051) Protein [Presence] in Urine by Test strip

463

1.58

4.37

3.0

1.8

—

(3039443) Prostate specific Ag panel - Serum or Plasma

733

0.57

4.37

1.6

1.7

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

8.29

4.31

7.3

4.6

—

(1761868) Lipid panel - Serum or Plasma

1219

9984

0.87

4.26

3.2

2.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.69

4.26

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

341

1.67

4.22

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

9.83

4.19

1.0

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

419

0.45

4.06

1.9

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

314

1.67

3.94

1.9

2.4

u/l

4968.5

6237.0

0.12

128

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

185

1.88

3.85

1.8

u/field

1.8

1.6

0.09

(3028707) Methadone [Presence] in Urine by Screen method

154

1.97

3.84

2.4

2.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

6.63

3.83

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

10.32

3.80

1.0

—

(40768441) Liver Pathology biopsy report

187

1.86

3.73

1.5

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1059

6967

1.15

3.72

3.0

3.1

ug/l

0.7

0.9

8.25

750

4745

(3013139) Helicobacter pylori Ag [Presence] in Stool

240

1365

1.31

3.70

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.83

3.70

5.6

7.5

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

4.34

3.70

1.5

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.69

3.66

1.2

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

248

1.73

3.66

1.0

1.1

u/ml

14.9

3.3

0.71

125

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

8.60

3.51

1.7

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.54

3.47

1.2

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.60

3.38

1.8

2.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.69

3.36

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.13

3.27

1.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

3.19

3.27

1.2

u/l

18.7

19.7

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

2.42

3.26

1.0

ng/l

787.1

792.8

0.02

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

2.42

3.26

1.0

ng/l

34.8

30.7

0.12

(3030313) Adrenal Ab [Titer] in Serum

7.37

3.26

1.3

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.27

3.25

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.60

3.22

1.1

u/ml

1.0

74.5

—

(3037556) Urate [Mass/volume] in Serum or Plasma

2.67

3.19

1.4

1.5

—

(3019174) dRVVT (LA screen)

4.74

3.08

1.3

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.61

3.07

1.2

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

214

1234

1.29

3.04

2.9

4.0

u/ml

12752.5

2054.4

0.40

175

1076

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

5.36

3.03

2.3

1.6

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

5.36

3.03

2.3

1.6

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

6.45

3.03

1.0

1.4

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

6.45

3.03

1.1

1.0

—

(3034988) Calcium [Moles/volume] in Capillary blood

3.16

2.97

1.4

2.0

mmol/l

1.2

0.36

(3035933) Granulocytes/100 leukocytes in Blood

2.42

2.96

2.4

1.4

—

(4281824)

447

0.56

2.94

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

2.34

2.92

1.1

1.0

ng/l

329.0

281.8

—

(3002523) Influenza virus A Ag [Presence] in Specimen

319

1.55

2.87

1.2

1.1

—

(3006462) Nitrate [Presence] in Urine

2.03

2.84

4.7

2.7

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

5.73

2.83

1.1

1.0

—

(3025315) Body weight

5.73

2.83

5.3

3.9

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

2.46

2.76

1.6

1.3

pmol/l

17.9

14.2

—

(4211845)

110

1.95

2.73

4.4

2.7

—

(40768800) Prostate Pathology biopsy report

111

1110

0.73

2.69

1.1

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

271

0.46

2.69

1.2

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.30

2.68

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

319

1.53

2.67

1.2

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.16

2.64

1.3

1.7

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

5.16

2.64

1.7

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

5.16

2.64

1.1

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

5.16

2.64

1.0

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.21

2.55

1.0

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

3.00

2.54

1.6

1.8

mmol/l

1.2

0.39

(3043410) Blood group antigens tested for on Red Blood Cells

2.29

2.53

1.8

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

108

1.91

2.53

1.1

1.3

mmol/l

14.0

11.7

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

140

1.79

2.53

1.3

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

192

0.38

2.52

1.6

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

110

596

1.37

2.47

5.5

3.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

7.37

2.44

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

7.37

2.44

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

5.53

2.43

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.90

2.40

1.2

1.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

227

0.45

2.36

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

226

0.45

2.34

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

246

0.48

2.34

1.4

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

225

0.46

2.31

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

225

0.46

2.31

1.4

—

(40758292) HTLV I+II Ab panel - Serum

2.46

2.30

1.2

1.4

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

3.68

2.28

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.91

2.25

1.0

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.91

2.25

1.0

1.3

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

2.40

2.20

1.9

2.7

ug/l

1.4

0.00

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.97

2.18

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

4.42

2.09

1.3

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

4.42

2.09

1.0

1.1

u/l

7.8

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.42

2.09

1.0

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

452

3772

0.87

2.06

1.4

—

(3020650) Glucose [Presence] in Urine

2.07

2.06

1.5

1.2

—

(3026726) Creatinine [Moles/volume] in Specimen

3.27

2.05

2.0

1.5

umol/l

469.4

966.6

—

(3022689) Creatine [Moles/volume] in Urine

2.62

2.04

1.6

1.5

—

(3040893) Potassium [Moles/volume] in Capillary blood

5.26

2.03

3.2

1.3

mmol/l

4.5

4.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

328

1.44

2.03

1.6

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

151

0.44

2.00

1.1

1.5

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

2.73

2.00

2.0

4.0

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

2.73

2.00

1.2

1.8

77.0

68.2

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

2.73

2.00

1.2

1.8

mu/l

433.0

499.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

496

3243

1.14

1.95

4.7

3.8

32.2

32.1

0.08

369

1894

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.44

1.93

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.44

1.93

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

197

0.48

1.88

1.4

1.5

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

4.60

1.86

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.95

1.85

1.1

1.4

—

(4094501)

117

673

1.29

1.83

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.46

1.83

1.5

1.1

umol/24h

0.8

0.7

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.22

1.82

1.0

1.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

192

0.50

1.76

1.3

1.4

—

(3005033) Fetal Nuchal fold Thickness US

190

0.50

1.71

1.3

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.40

1.70

1.0

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

136

1.63

1.68

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

168

0.48

1.65

1.5

1.7

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.38

1.57

1.7

1.9

u/field

0.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.38

1.57

2.0

3.8

—

(4212803)

2.71

1.53

1.1

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.71

1.53

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

2.30

1.48

1.4

1.3

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

2.30

1.48

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.35

1.46

5.8

7.9

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.95

1.41

1.6

1.8

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.29

1.40

1.2

1.5

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.83

1.26

2.4

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

118

1046

0.83

1.24

2.1

1.5

mg/l

25.7

2.5

6.65

102

671

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

197

1.42

1.23

1.5

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

622

0.78

1.21

2.2

1.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.64

1.21

1.9

1.6

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.63

1.17

1.4

2.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

348

1.29

1.12

2.1

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.01

1.05

1.3

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

309

0.71

1.04

1.1

1.0

—

(3000285) Sodium [Moles/volume] in Blood

1.95

1.03

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

103

905

0.83

1.03

1.4

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

288

1.31

1.02

1.2

mmol/l

7.0

6.5

0.71

193

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

178

1144

1.15

1.02

1.7

—

(4198724)

1.80

1.01

1.2

1.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

203

1319

1.14

1.00

1.7

1.8

—

(3015183) Erythrocyte sedimentation rate

1.58

0.98

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.98

0.0

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.56

0.97

1.2

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.49

0.95

1.2

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

209

1.34

0.93

1.8

1.5

nmol/l

0.2

0.3

2.61

150

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

484

0.79

0.92

1.9

1.7

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.10

0.89

1.3

1.7

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.84

0.86

1.5

1.3

ng/l

186.4

103.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

510

0.81

0.84

1.5

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

105

662

1.17

0.82

1.4

iu/l

33.6

38.5

0.66

566

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

107

676

1.17

0.81

1.7

1.6

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

195

1.32

0.81

3.2

6.5

u/ml

110.3

68.8

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.17

0.76

1.6

10.5

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

620

0.84

0.73

1.7

1.4

pmol/l

112.7

185.0

2.46

605

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.94

0.70

2.2

1.2

umol/24h

1.9

1.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

591

1.15

0.61

6.7

2.5

mg/l

25.6

30.2

0.63

356

(3011288) Drugs identified in Urine by Screen method

269

1.21

0.54

8.3

1.9

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

215

0.79

0.49

1.5

1.2

pmol/l

60.2

75.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

134

1.26

0.44

1.3

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.67

0.44

1.2

1.9

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

208

1.20

0.44

1.7

1.5

g/l

1.0

0.09

208

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.33

0.41

2.0

1.8

—

(3033799) Differential panel - Peritoneal fluid

1.31

0.40

2.4

1.6

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.40

0.0

1.2

—

(3016879) Cocaine [Presence] in Urine

452

1.13

0.40

1.9

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.35

0.39

1.2

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

151

1.22

0.37

3.4

7.7

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

196

0.83

0.34

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.34

0.34

15.0

4.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.68

0.33

1.8

2.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

120

1.23

0.33

1.0

1.1

u/ml

0.8

2.2

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.36

0.31

1.9

1.7

pmol/l

33.0

54.2

—

(3028300) Cannabinoids [Presence] in Urine

497

1.10

0.30

1.9

1.5

—

(3027008) Opiates [Presence] in Urine

497

1.10

0.30

1.9

1.5

—

(3027944) Amphetamines [Presence] in Urine

491

1.08

0.23

1.8

1.5

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.22

0.0

1.1

—

(4038314)

0.00

0.22

0.0

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

493

1.08

0.22

1.9

1.5

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

223.4

—

(40768793) Breast Pathology biopsy report

756

0.94

0.20

1.4

1.3

—

(3044007) Cell count panel - Peritoneal fluid

1.15

0.13

1.9

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.15

0.10

1.0

—

(4133840)

1.09

0.07

1.0

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

606

0.97

0.07

3.1

3.2

u/ml

26.1

43.9

1.55

587

(3025130) Human papilloma virus identified in Specimen

300

0.96

0.07

1.8

1.7

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

117

1.07

0.05

1.0

1.2

u/ml

0.5

3.8

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

139

1.06

0.04

20.7

16.7

nmol/l

1365.3

1514.3

0.44

127

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

229

1692

1.00

0.01

1.4

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

196

0.98

0.00

1.2

1.3

u/l

35.3

37.7

0.12

176

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

135

0.98

0.00

16.8

11.1

nmol/l

845.0

945.8

0.38

125

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.97

0.00

2.7

2.2

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.98

0.00

1.0

—

(3016031) Almond IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

1.6

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

2.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: IBD_PULM – Respiratory diseases principally affecting the interstitium, IBD co-morbidites

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Respiratory diseases principally affecting the interstitium, IBD co-morbidites (IBD_PULM)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints